<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Cell Biol</journal-id><journal-title>The Journal of Cell Biology</journal-title><issn pub-type="ppub">0021-9525</issn><issn pub-type="epub">1540-8140</issn><publisher><publisher-name>The Rockefeller University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">10037795</article-id><article-id pub-id-type="pmc">2132941</article-id><article-categories><subj-group subj-group-type="heading"><subject>Regular Articles</subject></subj-group></article-categories><title-group><article-title>Activation of G<sub>12</sub>/G<sub>13</sub> Results in Shape Change and Rho/Rho-Kinase&#x02013;mediated Myosin Light Chain Phosphorylation in Mouse Platelets </article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Klages</surname><given-names>Birgit</given-names></name><xref ref-type="aff" rid="N0x3535ca0N0x4210eb0">&#x0002a;</xref></contrib><contrib contrib-type="author"><name><surname>Brandt</surname><given-names>Ursula</given-names></name><xref ref-type="aff" rid="N0x3535ca0N0x4210eb0">&#x0002a;</xref></contrib><contrib contrib-type="author"><name><surname>Simon</surname><given-names>Melvin I.</given-names></name><xref ref-type="aff" rid="N0x3535ca0N0x4210eb0">&#x02021;</xref></contrib><contrib contrib-type="author"><name><surname>Schultz</surname><given-names>G&#x000fc;nter</given-names></name><xref ref-type="aff" rid="N0x3535ca0N0x4210eb0">&#x0002a;</xref></contrib><contrib contrib-type="author"><name><surname>Offermanns</surname><given-names>Stefan</given-names></name><xref ref-type="aff" rid="N0x3535ca0N0x4210eb0">&#x0002a;</xref></contrib></contrib-group><aff id="N0x3535ca0N0x4210eb0"><label>&#x0002a;</label>Institut f&#x000fc;r Pharmakologie, Universit&#x000e4;tsklinikum Benjamin Franklin, Freie Universit&#x000e4;t Berlin, 14195 Berlin, Germany; and  <label>&#x02021;</label>Division of Biology, California Institute of Technology, Pasadena, California 91125</aff><author-notes><fn><p>Address correspondence to S. Offermanns, Institut f&#x000fc;r Pharmakologie,  Universit&#x000e4;tsklinikum Benjamin Franklin, Freie Universit&#x000e4;t Berlin, Thielallee 67-73, 14195 Berlin, Germany. Tel.: (49) 30-8445-1835. Fax: (49) 30-8445-1818. E-mail: <email>stoff&#x00040;zedat.fu-berlin.de</email></p></fn></author-notes><pub-date pub-type="ppub"><day>22</day><month>2</month><year>1999</year></pub-date><volume>144</volume><issue>4</issue><fpage>745</fpage><lpage>754</lpage><history><date date-type="received"><day>24</day><month>9</month><year>1998</year></date><date date-type="rev-recd"><day>19</day><month>1</month><year>1999</year></date></history><copyright-year>1999</copyright-year><abstract><p>Platelets respond to various stimuli with  rapid changes in shape followed by aggregation and secretion of their granule contents. Platelets lacking the  &#x003b1;-subunit of the heterotrimeric G protein G<sub>q</sub> do not aggregate and degranulate but still undergo shape change  after activation through thromboxane-A<sub>2 </sub>(TXA<sub>2</sub>) or  thrombin receptors. In contrast to thrombin, the TXA<sub>2</sub>  mimetic U46619 led to the selective activation of G<sub>12</sub>  and G<sub>13</sub> in G&#x003b1;<sub>q</sub>-deficient platelets indicating that these  G proteins mediate TXA<sub>2</sub> receptor-induced shape  change. TXA<sub>2</sub> receptor-mediated activation of G<sub>12</sub>/G<sub>13</sub>  resulted in tyrosine phosphorylation of pp72<sup>syk</sup> and  stimulation of pp60<sup>c-src</sup> as well as in phosphorylation of  myosin light chain (MLC) in G&#x003b1;<sub>q</sub>-deficient platelets.  Both MLC phosphorylation and shape change induced  through G<sub>12</sub>/G<sub>13</sub> in the absence of G&#x003b1;<sub>q</sub> were inhibited  by the C3 exoenzyme from <italic>Clostridium botulinum</italic>, by  the Rho-kinase inhibitor Y-27632 and by cAMP-analogue Sp-5,6-DCl-cBIMPS. These data indicate that  G<sub>12</sub>/G<sub>13</sub> couple receptors to tyrosine kinases as well as  to the Rho/Rho-kinase&#x02013;mediated regulation of MLC  phosphorylation. We provide evidence that G<sub>12</sub>/G<sub>13</sub>-mediated Rho/Rho-kinase&#x02013;dependent regulation of  MLC phosphorylation participates in receptor-induced  platelet shape change.</p></abstract><kwd-group><kwd>platelet</kwd><kwd>platelet shape change</kwd><kwd>G protein</kwd><kwd>Rho-kinase</kwd><kwd>myosin light chain phosphorylation</kwd></kwd-group></article-meta></front><body><p>T<sc>he</sc> functional responses of platelets to various full  platelet activators are well characterized and include secretion of granular contents, platelet aggregation, and platelet shape change. Platelets are discoid in  their resting state and upon activation by most stimuli rapidly change into a spheroid shape and extrude pseudopodia. This shape change is one of the earliest effects detectable in response to various platelet stimuli. Platelet shape  change is believed to be a prerequisite for full platelet activation including degranulation and aggregation. The activation of platelets is responsible for primary hemostasis  and underlies various pathological situations such as unstable angina pectoris, myocardial infarction, or cerebrovascular diseases.</p><p>Platelet shape change results from a rapid reorganization of the cytoskeleton including formation of new actin  filaments, disappearance of the marginal band of microtubules, and centralization of granules (<xref ref-type="bibr" rid="B65">Siess, 1989</xref>; <xref ref-type="bibr" rid="B74">Wurzinger, 1990</xref>; <xref ref-type="bibr" rid="B22">Fox, 1993</xref>; <xref ref-type="bibr" rid="B48">Morgenstern, 1997</xref>). Signal transduction mechanisms regulating platelet shape change are  ill defined. An involvement of tyrosine phosphorylation  events, myosin light chain phosphorylation and polyphosphoinositide-induced actin polymerization have been suggested (<xref ref-type="bibr" rid="B14">Daniel et al., 1984</xref>; <xref ref-type="bibr" rid="B30">Hartwig et al., 1995</xref>; <xref ref-type="bibr" rid="B54">Negrescu  et al., 1995</xref>; <xref ref-type="bibr" rid="B43">Maeda et al., 1995</xref>). Several reports have demonstrated that, in contrast to full platelet activation, induction of platelet shape change does not require elevation of  the free cytosolic Ca<sup>2&#x0002b;</sup> concentration (<xref ref-type="bibr" rid="B63">Rink et al., 1982</xref>;  <xref ref-type="bibr" rid="B67">Simpson et al., 1986</xref>; <xref ref-type="bibr" rid="B60">Ohkubo et al., 1996</xref>). Consistent with  that, we recently demonstrated that incubation of G&#x003b1;<sub>q</sub>-deficient platelets with various stimuli failed to induce  phospholipase C activation and [Ca<sup>2&#x0002b;</sup>]<sub>i</sub> elevation as well  as aggregation and degranulation. Platelet shape change,  however, could still be elicited (<xref ref-type="bibr" rid="B59">Offermanns et al., 1997b</xref>).  Platelets do not contain G&#x003b1;<sub>11</sub>, a close homologue of G&#x003b1;<sub>q</sub>  (<xref ref-type="bibr" rid="B47">Milligan et al., 1993</xref>; <xref ref-type="bibr" rid="B36">Johnson et al., 1996</xref>; <xref ref-type="bibr" rid="B59">Offermanns et al.,  1997b</xref>).</p><p>The effect of full platelet stimuli like thromboxane A<sub>2</sub>  (TXA<sub>2</sub>)<sup>1</sup> and thrombin are mediated through G protein&#x02013; coupled receptors which have been shown to activate G<sub>q</sub>,  G<sub>i</sub>, G<sub>12</sub>, and G<sub>13</sub> (<xref ref-type="bibr" rid="B64">Shenker et al., 1991</xref>; <xref ref-type="bibr" rid="B34">Hung et al., 1992</xref>;  <xref ref-type="bibr" rid="B57">Offermanns et al., 1994</xref>; <xref ref-type="bibr" rid="B72">Ushikubi et al., 1994</xref>). G proteins  are heterotrimers which are defined by their &#x003b1;-subunits.  According to structural and functional similarities, G protein &#x003b1;-subunits are grouped into four families, G&#x003b1;<sub>q</sub>, G&#x003b1;<sub>i</sub>,  G&#x003b1;<sub>12</sub>, and G&#x003b1;<sub>s</sub> (<xref ref-type="bibr" rid="B66">Simon et al., 1991</xref>). Although G<sub>q</sub>-mediated  activation of phospholipase C &#x003b2;-isoforms appears to play a  central and essential role in agonist-induced platelet aggregation and secretion, G<sub>i</sub>-type G proteins are involved  in the inhibitory regulation of platelet adenylyl cyclase  (<xref ref-type="bibr" rid="B6">Brass et al., 1997</xref>, <xref ref-type="bibr" rid="B5">1988</xref>; <xref ref-type="bibr" rid="B59">Offermanns et al., 1997b</xref>). The  role of the G<sub>12</sub> family members, G<sub>12</sub> and G<sub>13</sub>, in the regulation of platelet function is unclear. The &#x003b1;-subunits of both  G proteins appear to be involved in the regulation of cell  growth and cell movement (<xref ref-type="bibr" rid="B16">Dhanasekaran and Dermott,  1996</xref>; <xref ref-type="bibr" rid="B58">Offermanns et al., 1997a</xref>). Since G<sub>12</sub>/G<sub>13</sub>-coupled receptors appear to also activate G<sub>q</sub> family members it has  been difficult to selectively study the cellular signaling  processes regulated by receptor-mediated activation of  G<sub>12</sub>/G<sub>13</sub>. Most knowledge about the signaling pathways influenced by G<sub>12</sub>/G<sub>13</sub> results from the use of constitutively  active forms of G&#x003b1;<sub>12</sub> and G&#x003b1;<sub>13</sub>. Either mutant has been  shown to cause Na<sup>&#x0002b;</sup>/H<sup>&#x0002b;</sup> exchanger activation, stimulation  of phospholipase D, cell transformation, and formation of  actin stress fibers through the small molecular weight GTPase Rho (<xref ref-type="bibr" rid="B7">Buhl et al., 1995</xref>; <xref ref-type="bibr" rid="B32">Hooley et al., 1996</xref>; <xref ref-type="bibr" rid="B23">Fromm et al.,  1997</xref>; <xref ref-type="bibr" rid="B61">Plonk et al., 1998</xref>). The effector directly regulated by  G&#x003b1;<sub>12</sub> and G&#x003b1;<sub>13</sub> has been elusive. However, the guanine nucleotide exchange factor (GEF) for Rho, p115RhoGEF,  has been shown to interact with G&#x003b1;<sub>12</sub> and G&#x003b1;<sub>13</sub> and represents a candidate effector (<xref ref-type="bibr" rid="B39">Kozasa et al., 1998</xref>; <xref ref-type="bibr" rid="B29">Hart et al.,  1998</xref>).</p><p>To study the possible role of G<sub>12</sub>/G<sub>13</sub> in the platelet  shape change response we took advantage of platelets  from G&#x003b1;<sub>q</sub>-deficient mice. In this report, we demonstrate  that selective activation of G<sub>12</sub>/G<sub>13</sub> is sufficient to induce  the platelet shape change reaction, and we provide evidence that this involves Rho/Rho-kinase&#x02013;mediated phosphorylation of the myosin light chain.</p><sec id="MaterialsMethods" sec-type="materials|methods"><title>Materials and Methods</title><sec><title>Materials</title><p>U46619 was from Cayman Chemical, thrombin, histone (subgroup f2b),  monoclonal anti-myosin light chain (MLC) antibody, and fluorescein  isothiocyanate (FITC)-phalloidin were from <named-content content-type="company" xlink:href="sigma">Sigma</named-content>. Sp-5,6-DCl-cBIMPS  and 8-pCPT-cGMP were from Biolog. Y-27632 was kindly provided by  Yoshitomi Pharmaceutical Industries, <italic>Clostridium botulinum</italic> C3-exoenzyme was a donation from I. Just and K. Aktories (both from University  of Freiburg, Freiburg, Germany) or was purchased from Upstate Biotechnologies, anti-pp72<sup>syk</sup> antibodies as well as anti-phosphotyrosine antibodies were from <named-content content-type="company" xlink:href="sbct">Santa Cruz Biotechnology</named-content>, and anti-pp60<sup>v-src</sup> antibodies  were from Oncogene. Antisera against G protein &#x003b1;-subunits have been  described (<xref ref-type="bibr" rid="B57">Offermanns et al., 1994</xref>; <xref ref-type="bibr" rid="B40">Laugwitz et al., 1994</xref>).</p></sec><sec><title>Platelet Preparation and Aggregation</title><p>Whole blood was collected from normal and G&#x003b1;<sub>q</sub>-deficient mice anesthetized with pentobarbital by puncturing the inferior vena cava with heparinized syringes at a final concentration of 25 U heparin/ml blood. The  blood from three or four G&#x003b1;<sub>q</sub>-deficient mice and wild-type mice was  pooled for each platelet aggregation experiment. Blood was diluted with  half the volume of Hepes-Tyrode-buffer (134 mM NaCl, 0.34 mM  Na<sub>2</sub>HPO<sub>4</sub>, 2.9 mM KCl, 12 mM NaHCO<sub>3</sub>, 20 mM Hepes, 5 mM glucose,  1 mM MgCl<sub>2</sub>, pH 7.3), and platelet rich plasma (PRP) was obtained by  centrifugation for 7.5 min at 250 <italic>g</italic>. Thereafter, prostacyclin at a final concentration of 300 nM was added to the PRP, and platelets were pelleted  by centrifugation at 1,200 <italic>g</italic> for 5 min. The platelet pellet was resuspended  in Hepes-Tyrode buffer and incubated for 30 min at 37&#x000b0;C. Platelet suspension was adjusted to 300,000 platelets per microliter with Hepes-Tyrode  buffer. Optical aggregation experiments were conducted in a four-channel  aggregometer (model Aggrecorder II PA-3220; Kyoto Daiichi Kagaku).  Preincubation in Hepes-Tyrode buffer without and with cGMP and  cAMP analogues and Y-27632 was performed for 20 min at room temperature. Immediately before the aggregation experiments, platelets were  preincubated for 1 min at 37&#x000b0;C in Hepes-Tyrode buffer containing 1 mM  CaCl<sub>2</sub>.</p></sec><sec><title>Photolabeling of Membrane Proteins and  Immunoprecipitation of G&#x003b1;-subunits</title><p>Platelet membranes were prepared and photolabeled as described (<xref ref-type="bibr" rid="B57">Offermanns et al., 1994</xref>). In brief, cell membranes (50&#x02013;100 &#x003bc;g of protein per assay tube) were incubated at 30&#x000b0;C in a buffer containing 0.1 mM EDTA,  10 mM MgCl<sub>2</sub>, 30 mM NaCl, 1 mM benzamidine, and 50 mM Hepes-NaOH, pH 7.4. After 3 min of preincubation in the absence and presence  of receptor agonist, samples were incubated for another 15 min with 10&#x02013;20  nM [&#x003b1;-<sup>32</sup>P]GTP azidoanilide (130 kBq per tube). [&#x003b1;-<sup>32</sup>P]GTP azidoanilide  was synthesized and purified as described (<xref ref-type="bibr" rid="B56">Offermanns et al., 1991</xref>). For  photolabeling of G<sub>i</sub> &#x003b1;-subunits, 5 &#x003bc;M GDP was present in the incubation  buffer. Samples were washed, dissolved in labeling buffer, and then irradiated as described (<xref ref-type="bibr" rid="B57">Offermanns et al., 1994</xref>). Photolabeled membranes  were pelleted and proteins were predenatured in SDS. Solubilized membranes were preabsorbed with protein A&#x02013;Sepharose beads, and immunoprecipitation was done as described (<xref ref-type="bibr" rid="B40">Laugwitz et al., 1994</xref>).</p></sec><sec><title>SDS-PAGE and Immunoblotting</title><p>SDS-PAGE of photolabeled proteins was performed on 10% (wt/vol)  acrylamide gels. Photolabeled membrane proteins were visualized by autoradiography of the dried gels. Blotting of membrane proteins separated  by SDS-PAGE, processing of immunoblots, and detection of immunoreactive proteins by chemiluminescence procedure (<named-content content-type="company" xlink:href="amersham">Amersham</named-content>) has been  described (<xref ref-type="bibr" rid="B40">Laugwitz et al., 1994</xref>).</p></sec><sec><title>Determination of Cellular cAMP Levels</title><p>Platelets (10<sup>8</sup> per tube) were preincubated for 15 min with 300 &#x003bc;M 3-isobutyl-1-methylxanthine and 20 &#x003bc;M 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (Ro 20-1724) and incubated for 20 min in the absence and  presence of receptor agonists. The reaction was stopped by the addition of  300 &#x003bc;l of ice-cold 10% (wt/vol) trichloracetic acid. Samples were kept for  10 min on ice, and 180 &#x003bc;l of 1 M Tris, pH 9.8, was added to neutralize the  sample. Cyclic AMP was determined by the competitive-binding assay  (<xref ref-type="bibr" rid="B26">Gilman and Murad, 1974</xref>). In brief, samples were incubated for 2 h with 2  pmol of [8-<sup>3</sup>H]cAMP (925 Gbq/mmol; <named-content content-type="company" xlink:href="amersham">Amersham</named-content>) and 62.5 &#x003bc;g of cAMP-dependent protein kinase purified from porcine heart (<named-content content-type="company" xlink:href="sigma">Sigma</named-content>) in a final  volume of 200 &#x003bc;l at 4&#x000b0;C. Then, 4% (wt/vol) charcoal in 5 mM EDTA and  50 mM Tris-HCl, pH 7.5, was added, and samples were immediately centrifuged for 2 min at 12,000 <italic>g</italic>. Supernatants were counted in a liquid scintillation counter, and the amount of cAMP in the test sample was calculated as described (<xref ref-type="bibr" rid="B26">Gilman and Murad, 1974</xref>).</p></sec><sec><title>Determination of Tyrosine Phosphorylation</title><p>Isolated platelets (1&#x02013;2 &#x000d7; 10<sup>7</sup> platelets per tube) were incubated in 40 &#x003bc;l  Hepes-Tyrode buffer at 37&#x000b0;C as indicated. Reactions were stopped by addition of 20 &#x003bc;l of 3&#x000d7; sample buffer containing a final concentration of  1 mM Na<sub>3</sub>VO<sub>4</sub>. Heated samples were separated by SDS-PAGE on 10%  gels. Immunoblotted proteins were analyzed for phosphotyrosine with an  antiphosphotyrosine antibody.</p></sec><sec><title>Immunoprecipitation and Immune Complex Kinase Assay</title><p>For immunoprecipitation of tyrosine kinases pp72<sup>syk</sup> and pp60<sup>c-src</sup>, platelet  suspensions (0.4&#x02013;1 &#x000d7; 10<sup>9</sup> platelets) were incubated in the absence or presence of 5 &#x003bc;M U46619 for the indicated time periods, and platelets were  lysed by addition of an equal volume of ice-cold 2&#x000d7; radioimmunoprecipitation assay (RIPA) buffer (final concentration: 1% Triton X-100, 0.1%  SDS, 1% sodium deoxycholate, 150 mM NaCl, 50 mM Hepes/NaOH, pH  7.4, 3 mM EDTA, 3 mM EGTA, 1 mM sodium orthovanadate, 1 mM phenylmethylsulfonyl fluoride, 20 &#x003bc;g/ml aprotinin, 20 &#x003bc;g/ml leupeptin). After  incubation for 20 min on ice, samples were centrifuged for 20 min at  15,000 <italic>g</italic> at 4&#x000b0;C, and incubated with 5 &#x003bc;g agarose conjugates of rabbit polyclonal anti-pp72<sup>syk</sup> IgG or 8 &#x003bc;l of agarose-conjugated mouse monoclonal  anti-pp60<sup>v-src</sup> IgG<sub>1</sub> for 2 h at 4&#x000b0;C. Immunoprecipitates were collected by  centrifugation at 15,000 <italic>g</italic> for 10 min at 4&#x000b0;C and were washed twice with  1&#x000d7; RIPA buffer, once with 1% Triton X-100, 0.3% SDS, 600 mM NaCl,  and 50 mM Tris-HCl, pH 7.4, and once with 300 mM NaCl, 10 mM  EDTA, 100 mM Tris-HCl, pH 7.4. For detection of pp72<sup>syk</sup> phosphorylation, precipitated proteins were eluted with 40 &#x003bc;l of 1&#x000d7; SDS sample  buffer and separated by 10% polyacrylamide gels. Tyrosine phosphorylation of pp72<sup>syk</sup> and pp72<sup>syk</sup> protein were analyzed by immunoblotting. The  anti-pp60<sup>c-src</sup> immunoprecipitates were divided into two aliquots; one was  analyzed by anti-pp60<sup>c-src</sup> immunoblotting, and the other was subjected to  in vitro kinase assay. To examine in vitro kinase activity, precipitates were  incubated for 5 min at 25&#x000b0;C in kinase buffer containing 25 mM Hepes/ NaOH, pH 7.4, 10 mM MnCl<sub>2</sub>, 1 &#x003bc;M ATP (7 &#x003bc;Ci of [&#x003b3;-<sup>32</sup>P]ATP/tube), and  0.25 mg/ml histone. Reaction was terminated by addition of 2&#x000d7; sample  buffer, and samples were subjected to SDS-PAGE. Phosphorylation of  histone was analyzed by autoradiography of dried gels.</p></sec><sec><title>Scanning Electron Microscopy</title><p>Isolated platelets were preincubated under the indicated conditions.  Thereafter, platelets were incubated in the absence or presence of 1 U/ml  thrombin or 5 &#x003bc;M U46619 for 5 s at 37&#x000b0;C and then fixed for 10 min with  3% paraformaldehyde, 3.75% glutaraldehyde, 0.06 mM cacodylate buffer,  and 3.4 mM CaCl<sub>2</sub>. The fixed platelets were suction filtered onto polycarbonate filters (0.45 &#x003bc;m; Nucleopore) which had been preincubated with  10 &#x003bc;g/ml polylysine. Filters were washed three times with 0.9% NaCl and  dehydrated stepwise in aqueous ethanol. After exchange of ethanol for  hexadimethyldisilazane, samples were air-dried and sputtered with gold.  Scanning electron microscopy was carried out on a <named-content content-type="company" xlink:href="zeiss">Zeiss</named-content>-Gemini instrument using a beam voltage of 5 kV.</p></sec><sec><title>MLC Phosphorylation</title><p>MLC phosphorylation was determined as described (<xref ref-type="bibr" rid="B15">Daniel and Sellers,  1992</xref>). Isolated platelets (1&#x02013;2 &#x000d7; 10<sup>7</sup> platelets per tube) were incubated in  30 &#x003bc;l Hepes-Tyrode buffer at 37&#x000b0;C as indicated. Reactions were stopped  by addition of 30 &#x003bc;l of 40% (vol/vol) perchloric acid. Precipitated samples  were kept on ice for 20&#x02013;30 min. After centrifugation (10 min at 15,000 <italic>g</italic> at  4&#x000b0;C) pellets were washed twice with acetone containing 10 mM DTT. 30 &#x003bc;l  of SDS sample buffer was added to dried samples, and proteins were solubilized by sonication for 30 min. Separation of proteins on urea/glycin gels  was done as described (<xref ref-type="bibr" rid="B15">Daniel and Sellers, 1992</xref>), and MLC was detected  after immunoblotting with an anti-MLC antibody.</p></sec><sec><title>Determination of F-actin Content</title><p>For actin filament content measurements, platelets (10<sup>8</sup>) were incubated  as indicated and fixed in 2% paraformaldehyde for 30 min at 37&#x000b0;C. Fixed  platelets were permeabilized with 0.1% Triton X-100, incubated with 10 &#x003bc;M  fluorescein isothiocyanate (FITC)-phalloidin (<named-content content-type="company" xlink:href="sigma">Sigma</named-content>) for 30 min at room  temperature and were then washed. Bound FITC-phalloidin was quantified using a fluorescence spectrophotometer (<named-content content-type="company" xlink:href="perkin">Perkin-Elmer</named-content>) (excitation at  495 nm; emission at 519 nm).</p></sec><sec><title>ADP Ribosylation of Platelet Lysates by C3 Exoenzyme</title><p>Washed platelets were incubated with the indicated concentrations of C3  exoenzyme in Hepes-Tyrode buffer. Platelets were lysed by addition of an  equal volume of lysis buffer (1.5% Triton X-100, 0.8% DOC, 0.2% SDS,  145 mM NaCl, 20 mM Hepes, pH 7.4, 3 mM EGTA, 0.3 mM phenylmethylsulfonyl fluoride, 5 &#x003bc;M leupeptin, 5 &#x003bc;g/ml aprotinin). ADP-ribosylation  using [<sup>32</sup>P]NAD was performed as described (<xref ref-type="bibr" rid="B49">Morii et al., 1992</xref>), and ribosylated samples were separated on 12% polyacrylamide gels.</p></sec></sec><sec id="Results"><title>Results</title><p>We have recently shown that G&#x003b1;<sub>q</sub>-deficient platelets do  not aggregate and secrete their granule contents in response to various stimuli indicating that G<sub>q</sub>-mediated activation of phospholipase C represents the central early signal transduction process leading to full platelet activation.  However, G<sub>q</sub>-deficient platelets were still able to undergo  ligand-induced platelet shape change. This suggests that G  proteins other than G<sub>q</sub> mediate the platelet shape change  response. Shape change induced by the TXA<sub>2</sub> analogue  U46619 could be observed in G&#x003b1;<sub>q</sub>-deficient platelets by  scanning electron microscopy of single cells (Fig. <xref ref-type="fig" rid="F1">1</xref>, A&#x02013;D)  as well as by measuring the light transmission of a platelet  suspension (Fig. <xref ref-type="fig" rid="F2">2</xref>). Shape change induced by U46619 in  G&#x003b1;<sub>q</sub>-deficient platelets and wild-type platelets was blocked  by the cAMP analogue Sp-5,6-DCl-cBIMPS but not by the  cGMP analogue 8-pCPT-cGMP, whereas both cyclic nucleotides blocked aggregation in wild-type platelets (Fig.  <xref ref-type="fig" rid="F2">2</xref>, A and B). Similar results were observed with thrombin-activated wild-type and G&#x003b1;<sub>q</sub>-deficient platelets (data not  shown). Preincubation of platelets with the recently described Rho-kinase inhibitor Y-27632 (<xref ref-type="bibr" rid="B71">Uehata et al.,  1997</xref>) blocked U46619-induced shape change both in wild-type and G&#x003b1;<sub>q</sub>-deficient platelets (Fig. <xref ref-type="fig" rid="F1">1</xref>, E&#x02013;H and Fig. <xref ref-type="fig" rid="F2">2</xref>, C  and D). To assess the role of Rho in agonist-induced platelet shape change we preincubated platelets for 2 h with  50 &#x003bc;g/ml C3 exoenzyme which ADP ribosylates and inactivates the small GTPase Rho (<xref ref-type="bibr" rid="B49">Morii et al., 1992</xref>). This C3  exoenzyme concentration and preincubation time resulted  in ADP-ribosylation of 70&#x02013;75% of endogenous Rho as determined by the inability of C3 exoenzyme to [<sup>32</sup>P]ADP-ribosylate Rho in subsequently prepared cell lysates (Fig.  <xref ref-type="fig" rid="F3">3</xref>). Longer preincubation times and higher C3 exoenzyme concentrations further increased the ADP-ribosylated fraction of Rho (Fig. <xref ref-type="fig" rid="F3">3</xref>), but resulted in preactivation of platelets (data not shown). C3-pretreated platelets  showed markedly reduced shape change in response to  U46619 with only partial spheration and occasional filopodia formation (Fig. <xref ref-type="fig" rid="F1">1</xref>, I&#x02013;L and Fig. <xref ref-type="fig" rid="F2">2</xref> E).   </p><p>Since platelet shape change including protrusion of  filopodia and lamellipodia is accompanied by actin polymerization (<xref ref-type="bibr" rid="B65">Siess, 1989</xref>; <xref ref-type="bibr" rid="B74">Wurzinger, 1990</xref>; <xref ref-type="bibr" rid="B22">Fox, 1993</xref>) we  measured F-actin content in wild-type and G&#x003b1;<sub>q</sub>-deficient  platelets (Fig. <xref ref-type="fig" rid="F4">4</xref>). U46619 induced an increase in F-actin  content of both, wild-type and G&#x003b1;<sub>q</sub>-deficient platelets,  which could be completely blocked by Y-27632. Reduction  of the amount of functional Rho by pretreatment with 50  &#x003bc;g/ml C3 exoenzyme for 2 h markedly reduced the effect  of U46619 in wild-type and G&#x003b1;<sub>q</sub>-deficient platelets. </p><p>To identify the G proteins mediating receptor-induced  platelet shape change we studied the coupling of TXA<sub>2  </sub>and thrombin receptors to heterotrimeric G proteins in  wild-type and G&#x003b1;<sub>q</sub>-deficient mouse platelets. Receptors  for both, thrombin and TXA<sub>2</sub>, have been shown to be able  to couple to members of the G<sub>q</sub>, G<sub>12</sub>, and G<sub>i</sub> families  (<xref ref-type="bibr" rid="B64">Shenker et al., 1991</xref>; <xref ref-type="bibr" rid="B34">Hung et al., 1992</xref>; <xref ref-type="bibr" rid="B57">Offermanns et al.,  1994</xref>; <xref ref-type="bibr" rid="B72">Ushikubi et al., 1994</xref>). In membranes of human  platelets, receptors activated by thrombin couple to G<sub>q</sub>,  G<sub>12</sub>, G<sub>13</sub>, and G<sub>i</sub>, whereas TXA<sub>2</sub> receptors only activate  G<sub>q</sub>, G<sub>12</sub>, and G<sub>13</sub> (<xref ref-type="bibr" rid="B57">Offermanns et al., 1994</xref>; <xref ref-type="bibr" rid="B6">Brass et al.,  1997</xref>). Photolabeling of receptor-activated G proteins in  mouse platelet membranes and subsequent immunoprecipitation of individual G protein &#x003b1;-subunits showed that  in wild-type mouse platelets, activated TXA<sub>2</sub> and thrombin receptors couple to G<sub>q</sub>, G<sub>12</sub>, and G<sub>13</sub>, whereas G<sub>i</sub> was  only activated through the thrombin receptor (Fig. <xref ref-type="fig" rid="F5">5</xref> A).  Similarly, in membranes from G&#x003b1;<sub>q</sub>-deficient platelets, only  G<sub>12</sub> and G<sub>13</sub> were activated through the TXA<sub>2</sub> receptor,  whereas activated thrombin receptors coupled to G<sub>12</sub>, G<sub>13</sub>,  and G<sub>i</sub> (Fig. <xref ref-type="fig" rid="F5">5</xref> B and data not shown). Coupling of thrombin receptors to G<sub>i</sub> in murine platelets corresponded with  the ability of thrombin to decrease cAMP levels in wild-type as well as in G&#x003b1;<sub>q</sub>-deficient platelets, whereas activation of TXA<sub>2</sub> receptors had no effect on adenylyl cyclase  activity in wild-type or G&#x003b1;<sub>q</sub>-deficient platelets (data not  shown). These data clearly demonstrate that in G&#x003b1;<sub>q</sub>-deficient platelets thrombin-receptors couple to G<sub>12</sub>, G<sub>13</sub>, and  G<sub>i</sub>, whereas only G<sub>12</sub> and G<sub>13</sub> are activated through TXA<sub>2</sub>  receptors. Consequently, effects which can still be induced  by TXA<sub>2</sub> receptor agonists in G&#x003b1;<sub>q</sub>-deficient platelets like  the shape change response are mediated by G<sub>12</sub> and/or  G<sub>13</sub>. TXA<sub>2</sub>-activated G&#x003b1;<sub>q</sub>-deficient platelets therefore represent a model to study of G<sub>12</sub>/G<sub>13</sub>-mediated signaling processes. </p><p>Agonist-induced platelet activation results in tyrosine  phosphorylation of multiple proteins (<xref ref-type="bibr" rid="B20">Ferrell and Martin,  1988</xref>; <xref ref-type="bibr" rid="B52">Nakamura and Yamamura, 1989</xref>; <xref ref-type="bibr" rid="B28">Golden and Brugge,  1989</xref>). Phosphorylation of these proteins occurs in three  temporal phases which have been experimentally distinguished. Early tyrosine phosphorylation occurs by an integrin-independent mechanism, whereas the second and  third wave of tyrosine phosphorylation depends on the aggregation of platelets through binding of fibrinogen to  &#x003b1;<sub>IIb</sub>&#x003b2;<sub>3</sub>-integrin (glycoprotein IIb-IIIa) (<xref ref-type="bibr" rid="B13">Clark et al., 1994b</xref>).  In G&#x003b1;<sub>q</sub>-deficient platelets that do not aggregate in response to thrombin or U46619, only a subset of proteins  became tyrosine phosphorylated upon exposure of platelets to both stimuli compared with wild-type platelets (Fig.  <xref ref-type="fig" rid="F6">6</xref>, A and B). Most prominently, a rapid tyrosine phosphorylation of a protein of &#x0223c;72 kD could be observed in G&#x003b1;<sub>q</sub>-deficient platelets activated with thrombin and U46619. In  contrast, several proteins with relative molecular masses  of 40 and 95&#x02013;130 kD which were tyrosine phosphorylated  in wild-type platelets did not show increased tyrosine  phosphorylation in activated G&#x003b1;<sub>q</sub>-deficient platelets (Fig.  <xref ref-type="fig" rid="F6">6</xref>, A and B). </p><p>Platelets contain several tyrosine kinases (<xref ref-type="bibr" rid="B17">Dhar and  Shukla, 1993</xref>; <xref ref-type="bibr" rid="B13">Clark et al., 1994b</xref>; <xref ref-type="bibr" rid="B35">Jackson et al., 1996</xref>)  among which pp72<sup>syk</sup> and pp60<sup>c-src</sup> are rapidly activated after stimulation of platelets in an aggregation-independent  manner (<xref ref-type="bibr" rid="B73">Wong et al., 1992</xref>; <xref ref-type="bibr" rid="B70">Taniguchi et al., 1993</xref>; <xref ref-type="bibr" rid="B42">Maeda  et al., 1993</xref>; <xref ref-type="bibr" rid="B11">Clark and Brugge, 1993</xref>; <xref ref-type="bibr" rid="B12">Clark et al., 1994a</xref>).  To test whether the 72-kD protein that was tyrosine phosphorylated in response to U46619 and thrombin in G&#x003b1;<sub>q</sub>-deficient platelets represented pp72<sup>syk</sup>, we immunoprecipitated pp72<sup>syk</sup> from lysates of platelets exposed to U46619.  Anti-phosphotyrosine immunoblots of pp72<sup>syk</sup> immunoprecipitates demonstrated increased tyrosine phosphorylation of pp72<sup>syk</sup> in response to U46619 in G&#x003b1;<sub>q</sub>-deficient  platelets as well as in wild-type platelets (Fig. <xref ref-type="fig" rid="F6">6</xref> C). Autophosphorylation of pp72<sup>syk</sup> on tyrosine has been demonstrated to increase its enzymatic activity (<xref ref-type="bibr" rid="B70">Taniguchi et al.,  1993</xref>; <xref ref-type="bibr" rid="B12">Clark et al., 1994a</xref>; <xref ref-type="bibr" rid="B9">Chacko et al., 1994</xref>; <xref ref-type="bibr" rid="B24">Fujii et al.,  1994</xref>). Fig. <xref ref-type="fig" rid="F6">6</xref> C shows that incubation of wild-type and  G&#x003b1;<sub>q</sub>-deficient platelets with U46619 also resulted in a  rapid increase in the activity of pp60<sup>c-src</sup>. Increases in tyrosine kinase activity could be observed within 10 s after  addition of U46619 and were not affected by pretreatment  of platelets with Y-27632 or C3 exoenzyme (data not  shown). These data indicate that TXA<sub>2</sub> receptor-mediated  activation of G<sub>12</sub>/G<sub>13</sub> leads to rapid activation of the tyrosine kinases pp72<sup>syk</sup> and pp60<sup>c-src</sup> in mouse platelets.</p><p>MLC phosphorylation has been suggested to be involved in early processes during platelet activation (<xref ref-type="bibr" rid="B14">Daniel et al., 1984</xref>). To test whether TXA<sub>2</sub> receptor-G<sub>12</sub>/G<sub>13</sub>&#x02013; mediated signaling in G&#x003b1;<sub>q</sub>-deficient platelets resulted in  MLC phosphorylation, we activated platelets with U46619  for different times and separated phosphorylated and unphosphorylated MLC on urea/glycin polyacrylamide gels.  Separated proteins were blotted onto nitrocellulose filters  and MLC was detected using a specific antiserum. Fig. <xref ref-type="fig" rid="F7">7</xref> A  shows that U46619 caused phosphorylation of the total detectable pool of MLC in wild-type platelets within 10 s. Interestingly, a rapid and apparently complete phosphorylation of MLC was also observed in G&#x003b1;<sub>q</sub>-deficient platelets  activated by U46619. Chelation of extracellular Ca<sup>2&#x0002b;</sup> by  EGTA or preincubation of platelets with various tyrosine  kinase inhibitors had no effect on U46619-induced MLC  phosphorylation in wild-type and G&#x003b1;<sub>q</sub>-deficient platelets  (data not shown). Although the cAMP analogue Sp-5,6-DCl-cBIMPS completely inhibited MLC phosphorylation  in wild-type and G&#x003b1;<sub>q</sub>-deficient platelets the cGMP analogue  8-pCPT-cGMP was without effect (Fig. <xref ref-type="fig" rid="F7">7</xref>, B and C). In  smooth muscle cells and fibroblasts, the phosphorylation  state of MLC has been shown to be under dual control  of the Ca<sup>2&#x0002b;</sup>/calmodulin-activated myosin light chain kinase (MLCK) as well as of myosin-phosphatase (<xref ref-type="bibr" rid="B68">Somlyo  and Somlyo, 1994</xref>; <xref ref-type="bibr" rid="B8">Burridge and Chrzanowska-Wodnicka,  1996</xref>). Myosin-phosphatase has been demonstrated to be  regulated by Rho/Rho-kinase (<xref ref-type="bibr" rid="B37">Kimura et al., 1996</xref>; <xref ref-type="bibr" rid="B53">Narumiya et al., 1997</xref>). Since U46619-induced platelet shape  change was blocked by the Rho-kinase inhibitor Y-27632  and was greatly inhibited after reduction of the amount of  active Rho by C3 exoenzyme (Figs. <xref ref-type="fig" rid="F1">1</xref> and <xref ref-type="fig" rid="F2">2</xref>) we tested the  effect of C3 exoenzyme and Y-27632 on U46619-induced  phosphorylation of MLC. Fig. <xref ref-type="fig" rid="F7">7</xref>, D&#x02013;F shows that Y-27632  blocked and C3 exoenzyme markedly inhibited U46619-induced MLC-phosphorylation in wild-type as well as in  G&#x003b1;<sub>q</sub>-deficient platelets. Incomplete inhibition of MLC  phosphorylation by C3 exoenzyme was most likely due to  incomplete inactivation of Rho by C3 exoenzyme (see  Fig. <xref ref-type="fig" rid="F3">3</xref>). Y-27632 exerted its inhibitory effect on receptor-induced MLC phosphorylation with higher potency in  G&#x003b1;<sub>q</sub>-deficient platelets compared with wild-type platelets  (Fig. <xref ref-type="fig" rid="F7">7</xref>, D and E). Similarly, the effect of C3 exoenzyme  appeared to be more pronounced in the absence of G&#x003b1;<sub>q</sub>  (Fig. <xref ref-type="fig" rid="F7">7</xref> F). These data indicate that activation of G<sub>12</sub>/G<sub>13</sub>  through the TXA<sub>2</sub> receptor results in MLC phosphorylation and that this process involves Rho/Rho-kinase. The  data also provide further evidence for the concept that  MLC phosphorylation underlies platelet shape change. </p></sec><sec id="Discussion"><title>Discussion</title><p>Full platelet activators like TXA<sub>2</sub> and thrombin function  through G protein&#x02013;coupled receptors which activate G<sub>q</sub>,  G<sub>12</sub>, G<sub>13</sub>, and G<sub>i</sub> type G proteins (<xref ref-type="bibr" rid="B64">Shenker et al., 1991</xref>;  <xref ref-type="bibr" rid="B34">Hung et al., 1992</xref>; <xref ref-type="bibr" rid="B72">Ushikubi et al., 1994</xref>; <xref ref-type="bibr" rid="B57">Offermanns et al.,  1994</xref>). G&#x003b1;<sub>11</sub>, a close homologue of G&#x003b1;<sub>q</sub> and coexpressed  with G&#x003b1;<sub>q</sub> in most cells, is not present in platelets (<xref ref-type="bibr" rid="B47">Milligan  et al., 1993</xref>; <xref ref-type="bibr" rid="B36">Johnson et al., 1996</xref>; <xref ref-type="bibr" rid="B59">Offermanns et al., 1997b</xref>).  In G&#x003b1;<sub>q</sub>-deficient platelets, the TXA<sub>2</sub> mimetic U46619 and  thrombin fail to induce platelet aggregation and degranulation. This is accompanied by a lack of phospholipase C  activation and Ca<sup>2&#x0002b;</sup> mobilization after TXA<sub>2</sub> and thrombin receptor activation supporting the concept that G<sub>q</sub>-mediated phospholipase C activation represents the main  signaling process leading to full platelet activation (<xref ref-type="bibr" rid="B59">Offermanns et al., 1997b</xref>). Lack of G&#x003b1;<sub>q</sub>-mediated phospholipase  C activation did not interfere with the ability of U46619  and thrombin to induce platelet shape change as shown by  scanning electron microscopy of activated G&#x003b1;<sub>q</sub>-deficient  platelets (see Fig. <xref ref-type="fig" rid="F1">1</xref>) and measurement of light transmission through a suspension of G&#x003b1;<sub>q</sub>-deficient platelets (see  Fig. <xref ref-type="fig" rid="F2">2</xref>) (<xref ref-type="bibr" rid="B59">Offermanns et al., 1997b</xref>). Thus, induction of  platelet shape change through receptors of different platelet stimuli is mediated by G proteins other than G<sub>q</sub>, and  G&#x003b1;<sub>q</sub>-deficient platelets provide a good model to study the  mechanisms underlying receptor-induced shape change independently of secondary processes involving secretion  and aggregation.</p><p>To identify the G proteins mediating platelet shape  change we studied the coupling of TXA<sub>2 </sub>and thrombin receptors to G<sub>12</sub> family members and G<sub>i</sub>-type G proteins.  Studies in human platelets have provided evidence that  thrombin receptors but not TXA<sub>2</sub> receptors couple to G<sub>i</sub>-type G proteins resulting in an inhibition of adenylyl cyclase (<xref ref-type="bibr" rid="B1">Aktories and Jakobs, 1984</xref>; <xref ref-type="bibr" rid="B33">Houslay et al., 1986</xref>;  <xref ref-type="bibr" rid="B5">Brass et al., 1988</xref>; <xref ref-type="bibr" rid="B57">Offermanns et al., 1994</xref>). Similarly, in membranes from wild-type and G&#x003b1;<sub>q</sub>-deficient mouse platelets,  thrombin increased incorporation of GTP-azidoanilide  into G<sub>i</sub>, whereas U46619 was without effect (see Fig. <xref ref-type="fig" rid="F5">5</xref>).  Only thrombin was able to decrease cAMP-levels in wild-type and G&#x003b1;<sub>q</sub>-deficient platelets (data not shown). The  fact that thrombin but not TXA<sub>2</sub>-receptors couple to G<sub>i</sub>  in mouse platelets clearly demonstrates that G<sub>i</sub>-mediated  processes do not play a significant role in the regulation of  platelet shape change. Both activated TXA<sub>2</sub> (see Fig. <xref ref-type="fig" rid="F5">5</xref>)  and thrombin receptors (data not shown), coupled to G<sub>12</sub>  and G<sub>13</sub> in wild-type and G&#x003b1;<sub>q</sub>-deficient platelets. Thus, in  G&#x003b1;<sub>q</sub>-deficient platelets, the only G proteins found to be  activated through TXA<sub>2</sub> receptors were G<sub>12</sub> and G<sub>13</sub>. We  therefore conclude that G<sub>12</sub> and/or G<sub>13</sub> are the mediators  of ligand-induced platelet shape change and that platelet  shape change induced through TXA<sub>2</sub> receptors in G&#x003b1;<sub>q</sub>-deficient platelets can be regarded as a G<sub>12</sub>/G<sub>13</sub>-regulated  physiological cellular function.</p><p>The signaling mechanisms regulating receptor-dependent platelet shape change are incompletely understood.  Elevation of the cytosolic Ca<sup>2&#x0002b;</sup> concentration is necessary  for full platelet activation including granule secretion and  aggregation. However, there is good evidence that elevation of [Ca<sup>2&#x0002b;</sup>]<sub>i</sub> alone is not sufficient to induce platelet  shape change and that agonists can induce shape change  without an increase in phospholipase C activity and without an increase in [Ca<sup>2&#x0002b;</sup>]<sub>i</sub> (<xref ref-type="bibr" rid="B67">Simpson et al., 1986</xref>; <xref ref-type="bibr" rid="B54">Negrescu  et al., 1995</xref>; <xref ref-type="bibr" rid="B60">Ohkubo et al., 1996</xref>; <xref ref-type="bibr" rid="B59">Offermanns et al., 1997b</xref>).  Tyrosine phosphorylation of various proteins has been  associated with receptor-mediated induction of platelet  shape change since this occurs rapidly in a Ca<sup>2&#x0002b;</sup>- and  &#x003b1;<sub>IIb</sub>&#x003b2;<sub>3</sub>-integrin&#x02013;independent manner (<xref ref-type="bibr" rid="B13">Clark et al., 1994b</xref>;  <xref ref-type="bibr" rid="B55">Negrescu and Siess, 1996</xref>). The mechanism of early receptor-induced tyrosine phosphorylation is not known. Tyrosine kinases like pp72<sup>syk</sup> and pp60<sup>c-src</sup>, which are rapidly  activated in a partially &#x003b1;<sub>IIb</sub>&#x003b2;<sub>3</sub>-integrin&#x02013;independent manner, may be involved (<xref ref-type="bibr" rid="B13">Clark et al., 1994b</xref>; <xref ref-type="bibr" rid="B62">Presek and Martinson, 1997</xref>), and pp72<sup>syk</sup> has been implicated in the platelet shape change response in porcine platelets (<xref ref-type="bibr" rid="B43">Maeda et al.,  1995</xref>). However, there is clear evidence that activation of  pp72<sup>syk</sup> alone is not sufficient for induction of shape change  (<xref ref-type="bibr" rid="B55">Negrescu and Siess, 1996</xref>). We show here that TXA<sub>2</sub>-receptor&#x02013;mediated activation of G<sub>12</sub>/G<sub>13</sub> leads to tyrosine  phosphorylation of pp72<sup>syk</sup> and activation of pp60<sup>c-src</sup> (see  Fig. <xref ref-type="fig" rid="F6">6</xref>) supporting the concept that these tyrosine kinases  are involved in early platelet activation. These data also  indicate that G proteins of the G<sub>12</sub>-family can regulate tyrosine kinases. The mechanism of this regulation remains  unknown.</p><p>MLC phosphorylation has been implicated in the regulation of cytoskeletal reorganization during platelet shape  change (<xref ref-type="bibr" rid="B14">Daniel et al., 1984</xref>; <xref ref-type="bibr" rid="B50">Nachmias et al., 1985</xref>). Phosphorylated myosin interacts mainly with central actin filaments in platelets, and the forming myosin&#x02013;actin complex  has been suggested to be involved in the granule centralization process (<xref ref-type="bibr" rid="B21">Fox and Phillips, 1982</xref>; <xref ref-type="bibr" rid="B69">Stark et al., 1991</xref>;  <xref ref-type="bibr" rid="B22">Fox, 1993</xref>). The phosphorylation state of MLC is under  dual control of MLCK and myosin-phosphatase. It is well  established that increase in [Ca<sup>2&#x0002b;</sup>]<sub>i</sub> activates the Ca<sup>2&#x0002b;</sup>/ calmodulin-dependent MLCK. MLC phosphorylation by  MLCK leads to actin&#x02013;myosin interaction resulting in actin-stimulated ATPase activity of smooth muscle and nonmuscle myosin (<xref ref-type="bibr" rid="B68">Somlyo and Somlyo, 1994</xref>; <xref ref-type="bibr" rid="B38">Kohama et al.,  1996</xref>). Recently, it has been shown that upstream regulation of myosin phosphatase occurs independently of the  cytosolic free calcium concentration through phosphorylation and inactivation of its regulatory subunit by Rho-kinase, a specific target of the small GTPase Rho (<xref ref-type="bibr" rid="B37">Kimura et al., 1996</xref>; <xref ref-type="bibr" rid="B53">Narumiya et al., 1997</xref>). In addition,  Rho-kinase can directly phosphorylate MLC in vitro  (<xref ref-type="bibr" rid="B2">Amano et al., 1996</xref>). There is increasing evidence that  Rho/Rho-kinase&#x02013;mediated MLC phosphorylation is involved in contractile responses in various cell types like  vascular smooth muscle cells (<xref ref-type="bibr" rid="B71">Uehata et al., 1997</xref>), fibroblasts (<xref ref-type="bibr" rid="B10">Chihara et al., 1997</xref>), neuroblastoma cells (<xref ref-type="bibr" rid="B3">Amano  et al., 1998</xref>; <xref ref-type="bibr" rid="B31">Hirose et al., 1998</xref>), astrocytoma cells (<xref ref-type="bibr" rid="B44">Majumdar et al., 1998</xref>), or endothelial cells (<xref ref-type="bibr" rid="B19">Essler et al.,  1998</xref>). It is, however, unclear how the Rho-mediated pathway is regulated through receptors.</p><p>The TXA<sub>2</sub> mimetic U46619 caused a rapid phosphorylation of MLC in wild-type and G&#x003b1;<sub>q</sub>-deficient platelets (see  Fig. <xref ref-type="fig" rid="F7">7</xref>). Since U46619 does not lead to elevation of [Ca<sup>2&#x0002b;</sup>]<sub>i</sub>  in the absence of G&#x003b1;<sub>q </sub>(<xref ref-type="bibr" rid="B59">Offermanns et al., 1997b</xref>) and since  Rho-kinase inhibitor Y-27632 and C3 exoenzyme inhibited  U46619-induced MLC phosphorylation in G&#x003b1;<sub>q</sub>-deficient  platelets, we conclude that a Rho/Rho-kinase&#x02013;mediated  pathway regulating MLC phosphorylation operates in  platelets. Consistent with this, the Rho-kinase p160ROCK  has been shown to be phosphorylated upon activation of  human platelets in an &#x003b1;<sub>IIb</sub>&#x003b2;<sub>3</sub>-integrin&#x02013;independent way  (<xref ref-type="bibr" rid="B25">Fujita et al., 1997</xref>). In addition, Rho and Rho-kinase can  be coimmunoprecipitated with the myosin-binding subunit  of myosin phosphatase from human platelets, and treatment of platelets with a TXA<sub>2</sub>-mimetic leads to rapid  phosphorylation and inactivation of myosin phosphatase  (<xref ref-type="bibr" rid="B51">Nakai et al., 1997</xref>). Conflicting data exist with regard to  the role of Rho in early platelet activation as determined  by C3 exoenzyme treatment. This is most likely due to the  difficulties associated with the length of incubation and  the high concentration of C3 exoenzyme required to inactivate a sufficient fraction of Rho. Although partial inactivation of the RhoA pool in human platelets by C3 exoenzyme has been shown to inhibit platelet activation (<xref ref-type="bibr" rid="B49">Morii  et al., 1992</xref>), a recent report showed that ADP ribosylation  of &#x0223c;90% of Rho in human platelets did not affect inside-out signaling of integrin &#x003b1;<sub>IIb</sub>&#x003b2;<sub>3</sub>, ligand-induced aggregation  and F-actin content (<xref ref-type="bibr" rid="B41">Leng et al., 1998</xref>). Our data clearly  support a role of Rho in early platelet activation.</p><p>In wild-type platelets in which U46619 induces an elevation of [Ca<sup>2&#x0002b;</sup>]<sub>i</sub> and most likely leads to Ca<sup>2&#x0002b;</sup>/calmodulin-MLCK&#x02013;mediated MLC phosphorylation, Rho-kinase  blocker Y-27632 and C3 exoenzyme also inhibited MLC  phosphorylation induced by U46619. Interestingly, both  agents appeared to be less potent in wild-type platelets  than in G&#x003b1;<sub>q</sub>-deficient platelets (see Fig. <xref ref-type="fig" rid="F7">7</xref>, D&#x02013;F). This suggests that both, Ca<sup>2&#x0002b;</sup>-mediated activation of MLCK and  inhibition of myosin phosphatase through Rho/Rho-kinase  may synergistically increase MLC phosphorylation in activated wild-type platelets. In contrast, receptor-mediated  MLC phosphorylation in G&#x003b1;<sub>q</sub>-deficient platelets depends  on the Ca<sup>2&#x0002b;</sup>-independent, Rho-mediated pathway. Since  shape change could be inhibited by the C3 exoenzyme as  well as by Y-27632 in G&#x003b1;<sub>q</sub>-deficient platelets (see Figs. <xref ref-type="fig" rid="F1">1</xref>  and <xref ref-type="fig" rid="F2">2</xref>) we suggest that Rho/Rho-kinase&#x02013;mediated MLC  phosphorylation is involved in TXA<sub>2</sub> receptor-induced  platelet shape change.</p><p>Cyclic nucleotides like cAMP and cGMP mediate physiological inhibition of platelet activation through activation  of cAMP- and cGMP-dependent kinases. Although analogues of both cyclic nucleotides can block full platelet  activation, only cAMP analogues inhibit platelet shape  change (<xref ref-type="bibr" rid="B45">Matsuoka et al., 1989</xref>; <xref ref-type="bibr" rid="B46">Menshikov et al., 1993</xref>).  Similarly, we observed that the cAMP analogue Sp-5,6-DCl-cBIMPS but not the cGMP analogue 8-pCPT-cGMP  inhibited TXA<sub>2</sub> receptor-G<sub>12</sub>/G<sub>13</sub>&#x02013;mediated shape change  and MLC phosphorylation in G&#x003b1;<sub>q</sub>-deficient platelets (see  Figs. <xref ref-type="fig" rid="F2">2</xref> and <xref ref-type="fig" rid="F7">7</xref>). Inhibition of MLC phosphorylation by Sp-5,6-DCl-cBIMPS but not by 8-pCPT-cGMP suggests that  the Rho/Rho-kinase&#x02013;mediated signaling cascade may be  inhibited by the cAMP-dependent pathway. A similar  role of cAMP was suggested for the inhibition of Rho/ Rho-kinase&#x02013;mediated neurite remodeling and morphology change in epithelial-like cells (<xref ref-type="bibr" rid="B31">Hirose et al., 1998</xref>; <xref ref-type="bibr" rid="B18">Dong  et al., 1998</xref>).</p><p>Rho has been shown to be regulated by the activated  &#x003b1;-subunits of G<sub>12</sub> and G<sub>13</sub> (<xref ref-type="bibr" rid="B7">Buhl et al., 1995</xref>; <xref ref-type="bibr" rid="B27">Gohla et al.,  1998</xref>; <xref ref-type="bibr" rid="B39">Kozasa et al., 1998</xref>). Since G<sub>12</sub> and G<sub>13</sub> are the only  G proteins activated through TXA<sub>2</sub> receptors in G&#x003b1;<sub>q</sub>-deficient platelets and since TXA<sub>2</sub> receptor-mediated MLC  phosphorylation in G&#x003b1;<sub>q</sub>-deficient platelets was inhibited  by C3 exoenzyme and Rho-kinase inhibitor Y-27632 we  suggest that TXA<sub>2</sub> receptor-induced G<sub>12</sub>/G<sub>13</sub> activation results in MLC phosphorylation through Rho-mediated activation of Rho-kinase. Activated Rho-kinase may phosphorylate MLC directly or act through phosphorylation  and inhibition of myosin phosphatase. Additional, synergistic regulation of MLC phosphorylation in wild-type  platelets occurs through G<sub>q</sub>-mediated activation of MLCK.  The mechanism by which G<sub>12</sub>/G<sub>13</sub> activate Rho remains to  be elucidated. Epidermal growth factor tyrosine kinase  has recently been involved in the G&#x003b1;<sub>13</sub>-induced Rho-dependent actin stress fiber formation in fibroblasts (<xref ref-type="bibr" rid="B27">Gohla et  al., 1998</xref>). However, various tyrosine kinase inhibitors  were unable to block TXA<sub>2</sub> receptor-induced, G<sub>12</sub>/G<sub>13</sub>-mediated MLC phosphorylation in G&#x003b1;<sub>q</sub>-deficient platelets  (data not shown). This suggests that in platelets, G<sub>12</sub>/G<sub>13</sub>-induced Rho activation is not mediated by receptor- or  nonreceptor-tyrosine kinases. Another possibility is that  regulation of Rho by G<sub>12</sub>/G<sub>13</sub> is mediated by a Rho-specific GEF. Genetic evidence in <italic>Drosophila</italic> showed that  the <italic>Drosophila</italic> RhoGEF, DRhoGEF2, functions downstream of the <italic>Drosophila</italic> G<sub>12</sub>/G<sub>13</sub> homologue concertina  (<xref ref-type="bibr" rid="B4">Barrett et al., 1997</xref>), and it has recently been shown that  the related mammalian RhoGEF, p115 RhoGEF, can directly link G&#x003b1;<sub>13</sub> to the regulation of Rho (<xref ref-type="bibr" rid="B29">Hart et al., 1998</xref>;  <xref ref-type="bibr" rid="B39">Kozasa et al., 1998</xref>).</p><p>Using G&#x003b1;<sub>q</sub>-deficient platelets which do not aggregate  and secrete but undergo shape change in response to various stimuli, we show that activation of G<sub>12</sub>/G<sub>13</sub> is sufficient  to induce platelet shape change. Thus, different G protein&#x02013;mediated signaling pathways appear to be specifically  involved in the regulation of distinct processes during receptor-induced platelet activation. Although G<sub>q</sub> is necessary for full platelet activation including aggregation and  secretion, activation of G<sub>i</sub> may counteract anti-aggregatory influences through inhibition of adenylyl cyclase, and  G<sub>12</sub>/G<sub>13</sub> appear to be centrally involved in the platelet  shape change response. Our data also indicate that G<sub>12</sub>/G<sub>13</sub>  can link receptors to tyrosine kinases as well as to Rho/ Rho-kinase&#x02013;mediated regulation of MLC phosphorylation, and we provide evidence that the latter pathway participates in the receptor-mediated induction of platelet  shape change.</p></sec></body><back><sec sec-type="display-objects"><title>Figures and Tables</title><fig position="float" id="F1"><label>Figure 1</label><caption><p>Scanning electron microscopy of  inactivated and activated wild-type and  G&#x003b1;<sub>q</sub>-deficient platelets. Wild-type platelets (A, B, E, F, I, and J) and G&#x003b1;<sub>q</sub>-deficient platelets (C, D, G, H, K, and L) were  preincubated for 30 min in the absence  (A&#x02013;D) or presence of 10 &#x003bc;M Y-27632  (E&#x02013;H) or were pretreated for 2 h with 50  &#x003bc;g/ml C3 exoenzyme (I&#x02013;L). Thereafter,  platelets were incubated for 5 s in the absence (A, C, E, G, I, and K) and presence  of 5 &#x003bc;M U46619 (B, D, F, H, J, and L),  fixed, and then analyzed as described in  Materials and Methods. Platelets incubated  for 2 h in C3-exoenzyme buffer alone  showed normal shape change in response  to U46619 (data not shown). Bar, 1 &#x003bc;m.</p></caption><graphic xlink:href="JCB9809112.f1"/></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p>Aggregation response of wild-type and G&#x003b1;<sub>q</sub>-deficient  platelets. Wild-type platelets (B and D) and platelets from G&#x003b1;<sub>q</sub>  (&#x02212;/&#x02212;) mice (A, C, and E) were preincubated for 20 min with the  indicated concentrations of 8-pCPT-cGMP (pCPT-cGMP) or Sp-5,6-DCl-cBIMPS (cBIMPS) (A and B) or for 30 min with the indicated concentrations of Y-27632 (C and D), and G&#x003b1;<sub>q</sub>-deficient  platelets were preincubated for 2 h in the absence or presence of  C3 exoenzyme (E). Thereafter, incubation was started by the addition of 5 &#x003bc;M U46619. Shown is the relative light transmission  through the platelet suspension. 0% represents transmission  through the platelet suspension before addition of U46619, and  100% represents transmission through the buffer alone. Upward  movements of the curve show decreases in light transmission indicating platelet shape change. Addition of stimuli is signified by  the arrows, 3-min traces are shown.</p></caption><graphic xlink:href="JCB9809112.f2"/></fig><fig position="float" id="F3"><label>Figure 3</label><caption><p>ADP ribosylation  of Rho in C3-treated platelets. (A) Platelets from wild-type and G&#x003b1;<sub>q</sub>-deficient animals were preincubated for 2 h  in the absence (&#x02212;) or presence of the indicated concentrations of C3 exoenzyme.  Thereafter, platelets were  lysed and subjected to C3-exoenzyme catalyzed (<sup>32</sup>P)  ADP ribosylation as described under Materials and  Methods. Shown is an autoradiogram with the position  of the 21-kD standard protein on the left. (B) Densitometric evaluation of bands  shown in A. Bars represent  mean of two independent experiments as percent of control.</p></caption><graphic xlink:href="JCB9809112.f3"/></fig><fig position="float" id="F4"><label>Figure 4</label><caption><p>Determination of F-actin content. Wild-type and G&#x003b1;<sub>q</sub>-deficient platelets were preincubated for 30 min in the absence  (c) or presence of 10 &#x003bc;M Y-27632 (Y) or were pretreated for 2 h  with 50 &#x003bc;g/ml C3 exoenzyme (C3). Thereafter, platelets were incubated for 10 s in the absence (&#x02212;) or presence of 5 &#x003bc;M U46619  (&#x0002b;), fixed, and then incubated with fluorescein isothiocyanate  (FITC)-phalloidin. Platelets incubated for 2 h in C3 exoenzyme  buffer alone showed full increase in F-actin content in response  to U46619 (data not shown). F-actin content was determined as  described in Materials and Methods. Shown are means &#x000b1; SD of  triplicates.</p></caption><graphic xlink:href="JCB9809112.f4"/></fig><fig position="float" id="F5"><label>Figure 5</label><caption><p>Receptor-dependent activation of G proteins  in membranes of wild-type  and G&#x003b1;<sub>q</sub>-deficient platelets.  Membranes from wild-type  (A) and G&#x003b1;<sub>q</sub>-deficient platelets (B) were photolabeled  with [&#x003b1;-<sup>32</sup>P]GTP azidoanilide in the absence (&#x02212;) or  presence of 5 &#x003bc;M U46619 or  5 U/ml thrombin (&#x0002b;). Membranes were solubilized and  G protein &#x003b1;-subunits (G&#x003b1;<sub>12</sub>,  G&#x003b1;<sub>13</sub>, G&#x003b1;<sub>q</sub>, and G&#x003b1;<sub>i</sub>) were  immunoprecipitated as described under Materials and  Methods. Anti-G&#x003b1;<sub>12</sub>, anti-G&#x003b1;<sub>13</sub>, anti-G&#x003b1;<sub>q/11 </sub>antisera,  and an antiserum recognizing  G&#x003b1;<sub>i1</sub>, G&#x003b1;<sub>i2</sub>, and G&#x003b1;<sub>i3</sub> were used. Precipitated proteins were subjected to SDS-PAGE. Shown are autoradiograms of dried SDS  gels with the position of the 43-kD standard protein shown on the  left.</p></caption><graphic xlink:href="JCB9809112.f5"/></fig><fig position="float" id="F6"><label>Figure 6</label><caption><p>Effect of thrombin and U46619 on tyrosine phosphorylation and pp72<sup>syk</sup> and pp60<sup>c-src</sup>-activity in wild-type and G&#x003b1;<sub>q</sub>-deficient platelets. (A) Wild-type and G&#x003b1;<sub>q</sub>-deficient platelets  were incubated for 30 s in the absence (&#x02212;) or presence of 5 U/ml  thrombin (Thr.) or 5 &#x003bc;M U46619 (TXA<sub>2</sub>). (B) Wild-type and  G&#x003b1;<sub>q</sub>-deficient platelets were incubated for the indicated times in  the absence (&#x02212;) or presence of 5 &#x003bc;M of the thromboxane A<sub>2</sub> mimetic U46619 (T). Cells were lysed and cellular proteins were  separated by SDS-PAGE and blotted on nitrocellulose filters.  Phosphotyrosine was detected by an antiphosphotyrosine antibody. Shown are autoluminograms with the position of standard  proteins shown on the left. (C) Wild-type (left) and G&#x003b1;<sub>q</sub>-deficient  platelets (right) were incubated with buffer (&#x02212;) or 5 &#x003bc;M U46619  (&#x0002b;) for the indicated times. Platelets were lysed and incubated  with agarose conjugates of anti-pp72<sup>syk</sup> IgG (IP: Syk) or of anti-pp60<sup>c-src</sup> IgG (IP: Src), and immunoprecipitates were analyzed by  immunoblotting with antiphosphotyrosine antibodies (WB: P-Y),  anti-pp72<sup>syk</sup> antibodies (WB: Syk), anti-pp60<sup>c-src</sup> antibodies (WB:  Src), or were subjected to in vitro kinase assays using histone as a  substrate (Histone-P).</p></caption><graphic xlink:href="JCB9809112.f6"/></fig><fig position="float" id="F7"><label>Figure 7</label><caption><p>U46619-induced MLC phosphorylation in wild-type and G&#x003b1;<sub>q</sub>-deficient  platelets. (A) Wild-type and G&#x003b1;<sub>q</sub>-deficient  platelets were incubated for the indicated  time periods with buffer (c) or 5 &#x003bc;M  U46619 (U). (B and C) Platelets were preincubated for 20 min without or with the  synthetic cyclic nucleotides 8-pCPT-cGMP (cGMP) or Sp-5,6-DCl-cBIMPS  (cAMP) at the indicated concentrations.  Thereafter, platelets were incubated for  10 s with buffer (c) or 5 &#x003bc;M U46619 (U).  (D and E) Platelets were preincubated for  30 min without or with the Rho-kinase inhibitor Y-27632 at the indicated concentrations (30 or 100 &#x003bc;M for wild-type and  10 or 30 &#x003bc;M for G&#x003b1;<sub>q</sub>-deficient platelets).  Incubation was conducted for 10 s with  buffer (c) or 5 &#x003bc;M U46619 (U). (F) Wild-type and G&#x003b1;<sub>q</sub>-deficient platelets were preincubated for 120 min without (&#x02212;) or with  50 &#x003bc;g/ml C3 exoenzyme (&#x0002b;). Thereafter,  platelets were incubated for 10 s with buffer (c) or 5 &#x003bc;M U46619 (U). Reactions were stopped by addition of perchloric acid, and phosphorylation of MLC was determined using urea/glycin gels as described in Materials and Methods. Shown are autoluminograms of anti-MLC immunoblots. Phosphorylation of MLC results in a faster mobility (lower position) of MLC on urea/glycin gels.</p></caption><graphic xlink:href="JCB9809112.f7"/></fig></sec><ack><p>We thank Yoshitomi Pharmaceutical Industries, Ltd. for kindly providing  us with Y-27632. </p><p>This work was supported by the Deutsche Forschungsgemeinschaft  (SFB 366) and the Fonds der Chemischen Industrie.</p></ack><glossary><title>Abbreviations used in this paper</title><def-list><def-item><term>MLC</term><def><p>myosin light chain</p></def></def-item><def-item><term>MLCK</term><def><p>myosin light chain kinase</p></def></def-item><def-item><term>GEF</term><def><p>guanine nucleotide exchange factor</p></def></def-item><def-item><term>TXA<sub>2</sub></term><def><p>thromboxane A<sub>2</sub></p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aktories</surname><given-names>K</given-names></name><name><surname>Jakobs</surname><given-names>KH</given-names></name></person-group><article-title>N<sub>i</sub>-mediated inhibition of human platelet adenylate cyclase by thrombin</article-title><source>Eur J Biochem</source><year>1984</year><volume>145</volume><fpage>333</fpage><lpage>338</lpage><pub-id pub-id-type="pmid">6437813</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amano</surname><given-names>M</given-names></name><name><surname>Ito</surname><given-names>M</given-names></name><name><surname>Kimura</surname><given-names>K</given-names></name><name><surname>Fukata</surname><given-names>Y</given-names></name><name><surname>Chihara</surname><given-names>K</given-names></name><name><surname>Nakano</surname><given-names>T</given-names></name><name><surname>Matsuura</surname><given-names>Y</given-names></name><name><surname>Kaibuchi</surname><given-names>K</given-names></name></person-group><article-title>Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase)</article-title><source>J Biol Chem</source><year>1996</year><volume>271</volume><fpage>20246</fpage><lpage>20249</lpage><pub-id pub-id-type="pmid">8702756</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amano</surname><given-names>M</given-names></name><name><surname>Chihara</surname><given-names>K</given-names></name><name><surname>Nakamura</surname><given-names>N</given-names></name><name><surname>Fukata</surname><given-names>Y</given-names></name><name><surname>Yano</surname><given-names>T</given-names></name><name><surname>Shibata</surname><given-names>M</given-names></name><name><surname>Ikebe</surname><given-names>M</given-names></name><name><surname>Kaibuchi</surname><given-names>K</given-names></name></person-group><article-title>Myosin II activation promotes neurite retraction during the action of Rho and Rho-kinase</article-title><source>Genes Cells</source><year>1998</year><volume>3</volume><fpage>177</fpage><lpage>188</lpage><pub-id pub-id-type="pmid">9619630</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>K</given-names></name><name><surname>Leptin</surname><given-names>M</given-names></name><name><surname>Settleman</surname><given-names>J</given-names></name></person-group><article-title>The Rho GTPase and a putative  RhoGEF mediate a signaling pathway for the cell shape changes in <italic>Drosophila</italic>gastrulation</article-title><source>Cell</source><year>1997</year><volume>91</volume><fpage>905</fpage><lpage>915</lpage><pub-id pub-id-type="pmid">9428514</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brass</surname><given-names>LF</given-names></name><name><surname>Woolkalis</surname><given-names>MJ</given-names></name><name><surname>Manning</surname><given-names>DR</given-names></name></person-group><article-title>Interactions in platelets between G proteins and the agonists that stimulate phospholipase C and inhibit adenylyl cyclase</article-title><source>J Biol Chem</source><year>1988</year><volume>263</volume><fpage>5348</fpage><lpage>5355</lpage><pub-id pub-id-type="pmid">2833506</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brass</surname><given-names>LF</given-names></name><name><surname>Manning</surname><given-names>DR</given-names></name><name><surname>Cichowski</surname><given-names>K</given-names></name><name><surname>Abrams</surname><given-names>CS</given-names></name></person-group><article-title>Signaling through G proteins in platelets: to the integrins and beyond</article-title><source>Thromb Haemost</source><year>1997</year><volume>78</volume><fpage>581</fpage><lpage>589</lpage><pub-id pub-id-type="pmid">9198220</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buhl</surname><given-names>AM</given-names></name><name><surname>Johnson</surname><given-names>ML</given-names></name><name><surname>Dhanasekaran</surname><given-names>N</given-names></name><name><surname>Johnson</surname><given-names>G</given-names></name></person-group><article-title>G&#x003b1;<sub>12</sub> and  G&#x003b1;<sub>13</sub>stimulate Rho-dependent stress fiber formation and focal adhesion assembly</article-title><source>J Biol Chem</source><year>1995</year><volume>270</volume><fpage>24631</fpage><lpage>24634</lpage><pub-id pub-id-type="pmid">7559569</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burridge</surname><given-names>K</given-names></name><name><surname>Chrzanowska-Wodnicka</surname><given-names>M</given-names></name></person-group><article-title>Focal adhesions, contractility, and signaling</article-title><source>Annu Rev Cell Dev Biol</source><year>1996</year><volume>12</volume><fpage>463</fpage><lpage>518</lpage><pub-id pub-id-type="pmid">8970735</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chacko</surname><given-names>GW</given-names></name><name><surname>Duchemin</surname><given-names>AM</given-names></name><name><surname>Coggeshall</surname><given-names>KM</given-names></name><name><surname>Osborne</surname><given-names>JM</given-names></name><name><surname>Brandt</surname><given-names>JT</given-names></name><name><surname>Anderson</surname><given-names>CL</given-names></name></person-group><article-title>Clustering of the platelet Fc gamma receptor induces noncovalent association with the tyrosine kinase p72<sup>syk</sup></article-title><source>J Biol Chem</source><year>1994</year><volume>269</volume><fpage>32435</fpage><lpage>32440</lpage><pub-id pub-id-type="pmid">7798242</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chihara</surname><given-names>K</given-names></name><name><surname>Amano</surname><given-names>M</given-names></name><name><surname>Nakamura</surname><given-names>N</given-names></name><name><surname>Yano</surname><given-names>T</given-names></name><name><surname>Shibata</surname><given-names>M</given-names></name><name><surname>Tokui</surname><given-names>T</given-names></name><name><surname>Ichikawa</surname><given-names>H</given-names></name><name><surname>Ikebe</surname><given-names>R</given-names></name><name><surname>Ikebe</surname><given-names>M</given-names></name><name><surname>Kaibuchi</surname><given-names>K</given-names></name></person-group><article-title>Cytoskeletal rearrangements and transcriptional activation of c-fos serum response element by Rho-kinase</article-title><source>J Biol Chem</source><year>1997</year><volume>272</volume><fpage>25121</fpage><lpage>25127</lpage><pub-id pub-id-type="pmid">9312122</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>EA</given-names></name><name><surname>Brugge</surname><given-names>JS</given-names></name></person-group><article-title>Redistribution of activated pp60<sup>c-src</sup>to integrin-dependent cytoskeletal complexes in thrombin-stimulated platelets</article-title><source>Mol Cell Biol</source><year>1993</year><volume>13</volume><fpage>1863</fpage><lpage>1871</lpage><pub-id pub-id-type="pmid">7680100</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>EA</given-names></name><name><surname>Shattil</surname><given-names>SJ</given-names></name><name><surname>Ginsberg</surname><given-names>MH</given-names></name><name><surname>Bolen</surname><given-names>J</given-names></name><name><surname>Brugge</surname><given-names>JS</given-names></name></person-group><article-title>Regulation of the protein tyrosine kinase pp72<sup>syk</sup> by platelet agonists and the integrin &#x003b1;<sub>IIb</sub>&#x003b2;<sub>3</sub></article-title><source>J Biol Chem</source><year>1994a</year><volume>269</volume><fpage>28859</fpage><lpage>28864</lpage><pub-id pub-id-type="pmid">7961845</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>EA</given-names></name><name><surname>Shattil</surname><given-names>SJ</given-names></name><name><surname>Brugge</surname><given-names>JS</given-names></name></person-group><article-title>Regulation of protein tyrosine kinases in platelets</article-title><source>Trends Biochem Sci</source><year>1994b</year><volume>19</volume><fpage>464</fpage><lpage>469</lpage><pub-id pub-id-type="pmid">7855888</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Daniel</surname><given-names>JL</given-names></name><name><surname>Molish</surname><given-names>IR</given-names></name><name><surname>Rigmaiden</surname><given-names>M</given-names></name><name><surname>Stewart</surname><given-names>G</given-names></name></person-group><article-title>Evidence for a role of myosin phosphorylation in the initiation of the platelet shape change response</article-title><source>J Biol Chem</source><year>1984</year><volume>259</volume><fpage>9826</fpage><lpage>9831</lpage><pub-id pub-id-type="pmid">6746669</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Daniel</surname><given-names>JL</given-names></name><name><surname>Sellers</surname><given-names>JR</given-names></name></person-group><article-title>Purification and characterization of platelet myosin</article-title><source>Methods Enzymol</source><year>1992</year><volume>215</volume><fpage>78</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">1435345</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dhanasekaran</surname><given-names>N</given-names></name><name><surname>Dermott</surname><given-names>JM</given-names></name></person-group><article-title>Signaling by the G<sub>12</sub>class of G proteins</article-title><source>Cell Signal</source><year>1996</year><volume>8</volume><fpage>235</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">8842523</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dhar</surname><given-names>A</given-names></name><name><surname>Shukla</surname><given-names>SD</given-names></name></person-group><article-title>Tyrosine kinases in platelet signalling</article-title><source>Br J  Haematol</source><year>1993</year><volume>84</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">8338765</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>JM</given-names></name><name><surname>Leung</surname><given-names>T</given-names></name><name><surname>Manser</surname><given-names>E</given-names></name><name><surname>Lim</surname><given-names>L</given-names></name></person-group><article-title>cAMP-induced morphological changes are counteracted by the activated RhoA small GTPase and the Rho kinase ROKalpha</article-title><source>J Biol Chem</source><year>1998</year><volume>273</volume><fpage>22554</fpage><lpage>22562</lpage><pub-id pub-id-type="pmid">9712882</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Essler</surname><given-names>M</given-names></name><name><surname>Amano</surname><given-names>M</given-names></name><name><surname>Kruse</surname><given-names>HJ</given-names></name><name><surname>Kaibuchi</surname><given-names>K</given-names></name><name><surname>Weber</surname><given-names>PC</given-names></name><name><surname>Aepfelbacher</surname><given-names>M</given-names></name></person-group><article-title>Thrombin inactivates myosin light chain phosphatase via Rho and its target Rho kinase in human endothelial cells</article-title><source>J Biol Chem</source><year>1998</year><volume>273</volume><fpage>21867</fpage><lpage>21874</lpage><pub-id pub-id-type="pmid">9705325</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferrell</surname><given-names>JE</given-names><suffix>Jr</suffix></name><name><surname>Martin</surname><given-names>GS</given-names></name></person-group><article-title>Platelet tyrosine-specific protein phosphorylation is regulated by thrombin</article-title><source>Mol Cell Biol</source><year>1988</year><volume>8</volume><fpage>3603</fpage><lpage>3610</lpage><pub-id pub-id-type="pmid">2464741</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>JE</given-names></name><name><surname>Phillips</surname><given-names>DR</given-names></name></person-group><article-title>Role of phosphorylation in mediating the association of myosin with the cytoskeletal structures of human platelets</article-title><source>J  Biol Chem</source><year>1982</year><volume>257</volume><fpage>4120</fpage><lpage>4126</lpage><pub-id pub-id-type="pmid">7040379</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>JEB</given-names></name></person-group><article-title>The platelet cytoskeleton</article-title><source>Thromb Haemost</source><year>1993</year><volume>70</volume><fpage>884</fpage><lpage>893</lpage><pub-id pub-id-type="pmid">8165606</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fromm</surname><given-names>C</given-names></name><name><surname>Coso</surname><given-names>OA</given-names></name><name><surname>Montaner</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>N</given-names></name><name><surname>Gutkind</surname><given-names>JS</given-names></name></person-group><article-title>The small  GTP-binding protein Rho links G protein-coupled receptors and G&#x003b1;<sub>12</sub>to the serum response element and to cellular transformation</article-title><source>Proc Natl Acad  Sci USA</source><year>1997</year><volume>94</volume><fpage>10098</fpage><lpage>10103</lpage><pub-id pub-id-type="pmid">9294169</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fujii</surname><given-names>C</given-names></name><name><surname>Yanagi</surname><given-names>S</given-names></name><name><surname>Sada</surname><given-names>K</given-names></name><name><surname>Nagai</surname><given-names>K</given-names></name><name><surname>Taniguchi</surname><given-names>T</given-names></name><name><surname>Yamamura</surname><given-names>H</given-names></name></person-group><article-title>Involvement of protein-tyrosine kinase p72<sup>syk</sup>in collagen-induced signal transduction in platelets</article-title><source>Eur J Biochem</source><year>1994</year><volume>226</volume><fpage>243</fpage><lpage>248</lpage><pub-id pub-id-type="pmid">7957255</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fujita</surname><given-names>A</given-names></name><name><surname>Saito</surname><given-names>Y</given-names></name><name><surname>Ishizaki</surname><given-names>T</given-names></name><name><surname>Maekawa</surname><given-names>M</given-names></name><name><surname>Fujisawa</surname><given-names>K</given-names></name><name><surname>Ushikubi</surname><given-names>F</given-names></name><name><surname>Narumiya</surname><given-names>S</given-names></name></person-group><article-title>Integrin-dependent translocation of p160ROCK to cytoskeletal complex in thrombin-stimulated human platelets</article-title><source>Biochem J</source><year>1997</year><volume>328</volume><fpage>769</fpage><lpage>775</lpage><pub-id pub-id-type="pmid">9396719</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gilman</surname><given-names>AG</given-names></name><name><surname>Murad</surname><given-names>F</given-names></name></person-group><article-title>Assay of cyclic nucleotides by receptor protein binding displacement</article-title><source>Methods Enzymol</source><year>1974</year><volume>38</volume><fpage>49</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">4375777</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gohla</surname><given-names>A</given-names></name><name><surname>Harhammer</surname><given-names>R</given-names></name><name><surname>Schultz</surname><given-names>G</given-names></name></person-group><article-title>The G-protein G<sub>13</sub> but not G<sub>12</sub>mediates signaling from lysophosphatidic acid receptor via epidermal growth factor receptor to Rho</article-title><source>J Biol Chem</source><year>1998</year><volume>273</volume><fpage>4653</fpage><lpage>4659</lpage><pub-id pub-id-type="pmid">9468525</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Golden</surname><given-names>A</given-names></name><name><surname>Brugge</surname><given-names>JS</given-names></name></person-group><article-title>Thrombin treatment induces rapid changes in tyrosine phosphorylation in platelets</article-title><source>Proc Natl Acad Sci USA</source><year>1989</year><volume>86</volume><fpage>901</fpage><lpage>905</lpage><pub-id pub-id-type="pmid">2464830</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hart</surname><given-names>MJ</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Kozasa</surname><given-names>T</given-names></name><name><surname>Roscoe</surname><given-names>W</given-names></name><name><surname>Singer</surname><given-names>WD</given-names></name><name><surname>Gilman</surname><given-names>AG</given-names></name><name><surname>Sternweis</surname><given-names>PC</given-names></name><name><surname>Bollag</surname><given-names>G</given-names></name></person-group><article-title>Direct stimulation of the guanine nucleotide  exchange activity of p115RhoGEF by G&#x003b1;<sub>13</sub></article-title><source>Science</source><year>1998</year><volume>280</volume><fpage>2112</fpage><lpage>2114</lpage><pub-id pub-id-type="pmid">9641916</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hartwig</surname><given-names>JH</given-names></name><name><surname>Bokoch</surname><given-names>GM</given-names></name><name><surname>Carpenter</surname><given-names>CL</given-names></name><name><surname>Janmey</surname><given-names>PA</given-names></name><name><surname>Taylor</surname><given-names>LA</given-names></name><name><surname>Toker</surname><given-names>A</given-names></name><name><surname>Stossel</surname><given-names>TP</given-names></name></person-group><article-title>Thrombin receptor ligation and activated rac uncap actin filament barbed ends through phosphoinositide synthesis in permeabilized human platelets</article-title><source>Cell</source><year>1995</year><volume>82</volume><fpage>643</fpage><lpage>653</lpage><pub-id pub-id-type="pmid">7664343</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirose</surname><given-names>M</given-names></name><name><surname>Ishizaki</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>N</given-names></name><name><surname>Uehata</surname><given-names>M</given-names></name><name><surname>Kranenburg</surname><given-names>O</given-names></name><name><surname>Moolenaar</surname><given-names>WH</given-names></name><name><surname>Matsumura</surname><given-names>F</given-names></name><name><surname>Maekawa</surname><given-names>M</given-names></name><name><surname>Bito</surname><given-names>H</given-names></name><name><surname>Narumiya</surname><given-names>S</given-names></name></person-group><article-title>Molecular dissection of the Rho-associated protein kinase (p160ROCK)- regulated neurite remodeling in neuroblastoma N1E-115 cells</article-title><source>J Cell Biol</source><year>1998</year><volume>141</volume><fpage>1625</fpage><lpage>1636</lpage><pub-id pub-id-type="pmid">9647654</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hooley</surname><given-names>R</given-names></name><name><surname>Yu</surname><given-names>CY</given-names></name><name><surname>Symons</surname><given-names>M</given-names></name><name><surname>Barber</surname><given-names>DL</given-names></name></person-group><article-title>G&#x003b1;<sub>13</sub> stimulates Na<sup>&#x0002b;</sup>-H<sup>&#x0002b;</sup>exchange through distinct Cdc42-dependent and RhoA-dependent pathways</article-title><source>J Biol Chem</source><year>1996</year><volume>271</volume><fpage>6152</fpage><lpage>6158</lpage><pub-id pub-id-type="pmid">8626403</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Houslay</surname><given-names>MD</given-names></name><name><surname>Bojanic</surname><given-names>D</given-names></name><name><surname>Wilson</surname><given-names>A</given-names></name></person-group><article-title>Platelet activating factor and  U44069 stimulate a GTPase activity in human platelets which is distinct from  the guanine nucleotide regulatory proteins, N<sub>s</sub> and N<sub>i</sub></article-title><source>Biochem J</source><year>1986</year><volume>234</volume><fpage>737</fpage><lpage>740</lpage><pub-id pub-id-type="pmid">3013161</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hung</surname><given-names>DT</given-names></name><name><surname>Wong</surname><given-names>YH</given-names></name><name><surname>Vu</surname><given-names>TKH</given-names></name><name><surname>Coughlin</surname><given-names>SR</given-names></name></person-group><article-title>The cloned platelet thrombin receptor couples to at least two distinct effectors to stimulate phosphoinositide hydrolysis and inhibit adenylyl cyclase</article-title><source>J Biol Chem</source><year>1992</year><volume>267</volume><fpage>20831</fpage><lpage>20834</lpage><pub-id pub-id-type="pmid">1328213</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>SP</given-names></name><name><surname>Schoenwaelder</surname><given-names>SM</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name><name><surname>Salem</surname><given-names>HH</given-names></name><name><surname>Cooray</surname><given-names>P</given-names></name></person-group><article-title>Non-receptor protein tyrosine kinases and phosphatases in human platelets</article-title><source>Thromb Haemost</source><year>1996</year><volume>76</volume><fpage>640</fpage><lpage>650</lpage><pub-id pub-id-type="pmid">8950767</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>GJ</given-names></name><name><surname>Leis</surname><given-names>LA</given-names></name><name><surname>Dunlop</surname><given-names>PC</given-names></name></person-group><article-title>Specificity of G&#x003b1;<sub>q</sub> and G&#x003b1;<sub>11</sub>gene expression in platelets and erythrocytes</article-title><source>Biochem J</source><year>1996</year><volume>318</volume><fpage>1023</fpage><lpage>1031</lpage><pub-id pub-id-type="pmid">8836152</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>K</given-names></name><name><surname>Ito</surname><given-names>M</given-names></name><name><surname>Amano</surname><given-names>M</given-names></name><name><surname>Chihara</surname><given-names>K</given-names></name><name><surname>Fukata</surname><given-names>Y</given-names></name><name><surname>Nakafuku</surname><given-names>M</given-names></name><name><surname>Yamamori</surname><given-names>B</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Nakano</surname><given-names>T</given-names></name><name><surname>Okawa</surname><given-names>K</given-names></name><name><surname>Iwamatsu</surname><given-names>A</given-names></name><name><surname>Kaibuchi</surname><given-names>K</given-names></name></person-group><article-title>Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase)</article-title><source>Science</source><year>1996</year><volume>273</volume><fpage>245</fpage><lpage>248</lpage><pub-id pub-id-type="pmid">8662509</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kohama</surname><given-names>K</given-names></name><name><surname>Ye</surname><given-names>LH</given-names></name><name><surname>Hayakawa</surname><given-names>K</given-names></name><name><surname>Okagaki</surname><given-names>T</given-names></name></person-group><article-title>Myosin light chain kinase: an actin-binding protein that regulates an ATP-dependent interaction with myosin</article-title><source>Trends Pharmacol Sci</source><year>1996</year><volume>17</volume><fpage>284</fpage><lpage>287</lpage><pub-id pub-id-type="pmid">8810874</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kozasa</surname><given-names>T</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Hart</surname><given-names>MJ</given-names></name><name><surname>Sternweis</surname><given-names>PC</given-names></name><name><surname>Singer</surname><given-names>WD</given-names></name><name><surname>Gilman</surname><given-names>AG</given-names></name><name><surname>Bollag</surname><given-names>G</given-names></name><name><surname>Sternweis</surname><given-names>PC</given-names></name></person-group><article-title>p115 RhoGEF, a GTPase activating protein for G&#x003b1;<sub>12</sub> and G&#x003b1;<sub>13</sub></article-title><source>Science</source><year>1998</year><volume>280</volume><fpage>2109</fpage><lpage>2111</lpage><pub-id pub-id-type="pmid">9641915</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laugwitz</surname><given-names>KL</given-names></name><name><surname>Spicher</surname><given-names>K</given-names></name><name><surname>Schultz</surname><given-names>G</given-names></name><name><surname>Offermanns</surname><given-names>S</given-names></name></person-group><article-title>Identification of receptor-activated G proteins: selective immunoprecipitation of photolabeled G-protein &#x003b1;-subunits</article-title><source>Methods Enzymol</source><year>1994</year><volume>237</volume><fpage>283</fpage><lpage>294</lpage><pub-id pub-id-type="pmid">7935004</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leng</surname><given-names>L</given-names></name><name><surname>Kashiwagi</surname><given-names>H</given-names></name><name><surname>Ren</surname><given-names>XD</given-names></name><name><surname>Shattil</surname><given-names>SJ</given-names></name></person-group><article-title>RhoA and the function of platelet integrin alphaIIbbeta3</article-title><source>Blood</source><year>1998</year><volume>91</volume><fpage>4206</fpage><lpage>4215</lpage><pub-id pub-id-type="pmid">9596668</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maeda</surname><given-names>H</given-names></name><name><surname>Taniguchi</surname><given-names>T</given-names></name><name><surname>Inazu</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Nakagawara</surname><given-names>G</given-names></name><name><surname>Yamamura</surname><given-names>H</given-names></name></person-group><article-title>Protein-tyrosine kinase p72<sup>syk</sup> is activated by thromboxane A<sub>2</sub>mimetic U44069 in platelets</article-title><source>Biochem Biophys Res Commun</source><year>1993</year><volume>197</volume><fpage>62</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">8250947</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maeda</surname><given-names>H</given-names></name><name><surname>Inazu</surname><given-names>T</given-names></name><name><surname>Nagai</surname><given-names>K</given-names></name><name><surname>Maruyama</surname><given-names>S</given-names></name><name><surname>Nakagawara</surname><given-names>G</given-names></name><name><surname>Yamamura</surname><given-names>H</given-names></name></person-group><article-title>Possible involvement of protein-tyrosine kinases such as p72<sup>syk</sup>in the disc-sphere change response of porcine platelets</article-title><source>J Biochem</source><year>1995</year><volume>117</volume><fpage>1201</fpage><lpage>1208</lpage><pub-id pub-id-type="pmid">7490261</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Majumdar</surname><given-names>M</given-names></name><name><surname>Seasholtz</surname><given-names>TM</given-names></name><name><surname>Goldstein</surname><given-names>D</given-names></name><name><surname>de Lanerolle</surname><given-names>P</given-names></name><name><surname>Brown</surname><given-names>JH</given-names></name></person-group><article-title>Requirement for Rho-mediated myosin light chain phosphorylation in thrombin-stimulated cell rounding and its dissociation from mitogenesis</article-title><source>J  Biol Chem</source><year>1998</year><volume>273</volume><fpage>10099</fpage><lpage>10106</lpage><pub-id pub-id-type="pmid">9553056</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsuoka</surname><given-names>I</given-names></name><name><surname>Nakahata</surname><given-names>N</given-names></name><name><surname>Nakanishi</surname><given-names>H</given-names></name></person-group><article-title>Comparison of inhibitory  effects of cyclic AMP and cyclic GMP on platelet activation induced by  thromboxane A<sub>2</sub>receptor stimulation</article-title><source>Jpn J Pharmacol</source><year>1989</year><volume>49</volume><fpage>142P</fpage></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Menshikov</surname><given-names>Y</given-names></name><name><surname>Ivanova</surname><given-names>K</given-names></name><name><surname>Schaefer</surname><given-names>M</given-names></name><name><surname>Drummer</surname><given-names>C</given-names></name><name><surname>Gerzer</surname><given-names>R</given-names></name></person-group><article-title>Influence of the cGMP analog 8-PCPT-cGMP on agonist-induced increases in  cytosolic ionized Ca<sup>2&#x0002b;</sup>and on aggregation of human platelets</article-title><source>Eur J Pharmacol</source><year>1993</year><volume>245</volume><fpage>281</fpage><lpage>284</lpage><pub-id pub-id-type="pmid">8392939</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Milligan</surname><given-names>G</given-names></name><name><surname>Mullaney</surname><given-names>I</given-names></name><name><surname>McCallum</surname><given-names>JF</given-names></name></person-group><article-title>Distribution and relative  levels of expression of the phosphoinositidase-C-linked G-proteins G<sub>q</sub>&#x003b1; and  G<sub>11</sub>&#x003b1;: absence of G<sub>11</sub>&#x003b1; in human platelets and haemopoietically derived cell lines</article-title><source>Biochim Biophys Acta</source><year>1993</year><volume>1179</volume><fpage>208</fpage><lpage>212</lpage><pub-id pub-id-type="pmid">8218363</pub-id></citation></ref><ref id="B48"><citation citation-type="other">Morgenstern, E. 1997. Human platelet morphology/ultrastructure. <italic>In</italic> Platelets  and Their Factors. F. Bruchhausen and U. Walter, editors. Springer-Verlag,  Berlin, Germany. 27&#x02013;60.</citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morii</surname><given-names>N</given-names></name><name><surname>Teru-uchi</surname><given-names>T</given-names></name><name><surname>Tominaga</surname><given-names>T</given-names></name><name><surname>Kumagai</surname><given-names>N</given-names></name><name><surname>Kozaki</surname><given-names>S</given-names></name><name><surname>Ushikubi</surname><given-names>F</given-names></name><name><surname>Narumiya</surname><given-names>S</given-names></name></person-group><article-title>A rho gene product in human blood platelets. II. Effects of the ADP-ribosylation by botulinum C3 ADP-ribosyltransferase on platelet aggregation</article-title><source>J Biol Chem</source><year>1992</year><volume>267</volume><fpage>20921</fpage><lpage>20926</lpage><pub-id pub-id-type="pmid">1400407</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nachmias</surname><given-names>VT</given-names></name><name><surname>Kavaler</surname><given-names>J</given-names></name><name><surname>Jacubowitz</surname><given-names>S</given-names></name></person-group><article-title>Reversible association of myosin with the platelet cytoskeleton</article-title><source>Nature</source><year>1985</year><volume>313</volume><fpage>70</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">3838108</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakai</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Kihira</surname><given-names>H</given-names></name><name><surname>Wada</surname><given-names>H</given-names></name><name><surname>Fujioka</surname><given-names>M</given-names></name><name><surname>Ito</surname><given-names>M</given-names></name><name><surname>Nakano</surname><given-names>T</given-names></name><name><surname>Kaibuchi</surname><given-names>K</given-names></name><name><surname>Shiku</surname><given-names>H</given-names></name><name><surname>Nishikawa</surname><given-names>M</given-names></name></person-group><article-title>Regulation of myosin phosphatase through phosphorylation of the myosin-binding subunit in platelet activation</article-title><source>Blood</source><year>1997</year><volume>90</volume><fpage>3936</fpage><lpage>3942</lpage><pub-id pub-id-type="pmid">9354661</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>S</given-names></name><name><surname>Yamamura</surname><given-names>H</given-names></name></person-group><article-title>Thrombin and collagen induce rapid phosphorylation of a common set of cellular proteins on tyrosine in human platelets</article-title><source>J Biol Chem</source><year>1989</year><volume>264</volume><fpage>7089</fpage><lpage>7091</lpage><pub-id pub-id-type="pmid">2468666</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Narumiya</surname><given-names>S</given-names></name><name><surname>Ishizaki</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>N</given-names></name></person-group><article-title>Rho effectors and reorganization of actin cytoskeleton</article-title><source>FEBS (Fed Eur Biochem Soc) Lett</source><year>1997</year><volume>410</volume><fpage>68</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">9247125</pub-id></citation></ref><ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Negrescu</surname><given-names>EV</given-names></name><name><surname>de Quintana</surname><given-names>KL</given-names></name><name><surname>Siess</surname><given-names>W</given-names></name></person-group><article-title>Platelet shape change induced by thrombin receptor activation. Rapid stimulation of tyrosine phosphorylation of novel protein substrates through an integrin- and Ca<sup>(2&#x0002b;)</sup>-independent mechanism</article-title><source>J Biol Chem</source><year>1995</year><volume>270</volume><fpage>1057</fpage><lpage>1061</lpage><pub-id pub-id-type="pmid">7836359</pub-id></citation></ref><ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Negrescu</surname><given-names>EV</given-names></name><name><surname>Siess</surname><given-names>W</given-names></name></person-group><article-title>Dissociation of the &#x003b1;<sub>IIb</sub>&#x003b2;<sub>3</sub>-integrin by  EGTA stimulates the tyrosine kinase pp72<sup>(syk)</sup>without inducing platelet activation</article-title><source>J Biol Chem</source><year>1996</year><volume>271</volume><fpage>26547</fpage><lpage>26553</lpage><pub-id pub-id-type="pmid">8900125</pub-id></citation></ref><ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Offermanns</surname><given-names>S</given-names></name><name><surname>Schultz</surname><given-names>G</given-names></name><name><surname>Rosenthal</surname><given-names>W</given-names></name></person-group><article-title>Identification of receptor-activated G proteins with photoreactive GTP analog, [&#x003b1;-<sup>32</sup>P]GTP azidoanilide</article-title><source>Methods Enzymol</source><year>1991</year><volume>195</volume><fpage>286</fpage><lpage>301</lpage><pub-id pub-id-type="pmid">1851930</pub-id></citation></ref><ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Offermanns</surname><given-names>S</given-names></name><name><surname>Laugwitz</surname><given-names>KL</given-names></name><name><surname>Spicher</surname><given-names>K</given-names></name><name><surname>Schultz</surname><given-names>G</given-names></name></person-group><article-title>G proteins of  the G<sub>12</sub> family are activated via thromboxane A<sub>2</sub>and thrombin receptors in human platelets</article-title><source>Proc Natl Acad Sci USA</source><year>1994</year><volume>91</volume><fpage>504</fpage><lpage>508</lpage><pub-id pub-id-type="pmid">8290554</pub-id></citation></ref><ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Offermanns</surname><given-names>S</given-names></name><name><surname>Mancino</surname><given-names>V</given-names></name><name><surname>Revel</surname><given-names>JP</given-names></name><name><surname>Simon</surname><given-names>MI</given-names></name></person-group><article-title>Vascular system defects and impaired cell chemokinesis as a result of G&#x003b1;<sub>13</sub>deficiency</article-title><source>Science</source><year>1997a</year><volume>275</volume><fpage>533</fpage><lpage>536</lpage><pub-id pub-id-type="pmid">8999798</pub-id></citation></ref><ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Offermanns</surname><given-names>S</given-names></name><name><surname>Toombs</surname><given-names>CF</given-names></name><name><surname>Hu</surname><given-names>YH</given-names></name><name><surname>Simon</surname><given-names>MI</given-names></name></person-group><article-title>Defective  platelet activation in G&#x003b1;<sub>q</sub>-deficient mice</article-title><source>Nature</source><year>1997b</year><volume>389</volume><fpage>183</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">9296496</pub-id></citation></ref><ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohkubo</surname><given-names>S</given-names></name><name><surname>Nakahata</surname><given-names>N</given-names></name><name><surname>Ohizumi</surname><given-names>Y</given-names></name></person-group><article-title>Thromboxane A<sub>2</sub>-mediated  shape change: independent of G<sub>q</sub>-phospholipase C-Ca<sup>2&#x0002b;</sup>pathway in rabbit platelets</article-title><source>Br J Pharmacol</source><year>1996</year><volume>117</volume><fpage>1095</fpage><lpage>1104</lpage><pub-id pub-id-type="pmid">8882602</pub-id></citation></ref><ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Plonk</surname><given-names>SG</given-names></name><name><surname>Park</surname><given-names>SK</given-names></name><name><surname>Exton</surname><given-names>JH</given-names></name></person-group><article-title>The alpha-subunit of the heterotrimeric G protein G<sub>13</sub>activates a phospholipase D isozyme by a pathway requiring Rho family GTPases</article-title><source>J Biol Chem</source><year>1998</year><volume>273</volume><fpage>4823</fpage><lpage>4826</lpage><pub-id pub-id-type="pmid">9478920</pub-id></citation></ref><ref id="B62"><citation citation-type="other">Presek, P., and E.A. Martinson. 1997. Platelet protein tyrosine kinases. <italic>In</italic>  Platelets and Their Factors. F. Bruchhausen and U. Walter, editors.  Springer-Verlag, Berlin, Germany. 263&#x02013;296.</citation></ref><ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rink</surname><given-names>TJ</given-names></name><name><surname>Smith</surname><given-names>SW</given-names></name><name><surname>Tsien</surname><given-names>RY</given-names></name></person-group><article-title>Cytoplasmic free Ca<sup>2&#x0002b;</sup> in human  platelets: Ca<sup>2&#x0002b;</sup>thresholds and Ca-independent activation for shape-change and secretion</article-title><source>FEBS (Fed Eur Biochem Soc) Lett</source><year>1982</year><volume>148</volume><fpage>21</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">6816632</pub-id></citation></ref><ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shenker</surname><given-names>A</given-names></name><name><surname>Goldsmith</surname><given-names>P</given-names></name><name><surname>Unson</surname><given-names>CG</given-names></name><name><surname>Spiegel</surname><given-names>AM</given-names></name></person-group><article-title>The G protein  coupled to the thromboxane A<sub>2</sub> receptor in human platelets is a member of  the novel G<sub>q</sub>family</article-title><source>J Biol Chem</source><year>1991</year><volume>266</volume><fpage>9309</fpage><lpage>9313</lpage><pub-id pub-id-type="pmid">1851174</pub-id></citation></ref><ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Siess</surname><given-names>W</given-names></name></person-group><article-title>Molecular mechanisms of platelet activation</article-title><source>Physiol Rev</source><year>1989</year><volume>69</volume><fpage>58</fpage><lpage>178</lpage><pub-id pub-id-type="pmid">2536184</pub-id></citation></ref><ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>MI</given-names></name><name><surname>Strathmann</surname><given-names>MP</given-names></name><name><surname>Gautam</surname><given-names>N</given-names></name></person-group><article-title>Diversity of G proteins in signal transduction</article-title><source>Science</source><year>1991</year><volume>252</volume><fpage>802</fpage><lpage>808</lpage><pub-id pub-id-type="pmid">1902986</pub-id></citation></ref><ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>AW</given-names></name><name><surname>Hallam</surname><given-names>TJ</given-names></name><name><surname>Rink</surname><given-names>TJ</given-names></name></person-group><article-title>Low concentrations of the  stable prostaglandin endoperoxide U44069 stimulate shape change in quin2-loaded platelets without a measurable increase in [Ca<sup>2&#x0002b;</sup>]<sub>i</sub></article-title><source>FEBS (Fed Eur  Biochem Soc) Lett</source><year>1986</year><volume>201</volume><fpage>301</fpage><lpage>305</lpage><pub-id pub-id-type="pmid">3086128</pub-id></citation></ref><ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Somlyo</surname><given-names>AP</given-names></name><name><surname>Somlyo</surname><given-names>AV</given-names></name></person-group><article-title>Signal transduction and regulation in smooth muscle</article-title><source>Nature</source><year>1994</year><volume>372</volume><fpage>231</fpage><lpage>236</lpage><pub-id pub-id-type="pmid">7969467</pub-id></citation></ref><ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stark</surname><given-names>F</given-names></name><name><surname>Golla</surname><given-names>R</given-names></name><name><surname>Nachmias</surname><given-names>VT</given-names></name></person-group><article-title>Formation and contraction of a microfilamentous shell in saponin-permeabilized platelets</article-title><source>J Cell Biol</source><year>1991</year><volume>112</volume><fpage>903</fpage><lpage>913</lpage><pub-id pub-id-type="pmid">1900299</pub-id></citation></ref><ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taniguchi</surname><given-names>T</given-names></name><name><surname>Kitagawa</surname><given-names>H</given-names></name><name><surname>Yasue</surname><given-names>S</given-names></name><name><surname>Yanagi</surname><given-names>S</given-names></name><name><surname>Sakai</surname><given-names>K</given-names></name><name><surname>Asahi</surname><given-names>M</given-names></name><name><surname>Ohta</surname><given-names>S</given-names></name><name><surname>Takeuchi</surname><given-names>F</given-names></name><name><surname>Nakamura</surname><given-names>S</given-names></name><name><surname>Yamamura</surname><given-names>H</given-names></name></person-group><article-title>Protein-tyrosine kinase  p72<sup>syk</sup> is activated by thrombin and is negatively regulated through Ca<sup>2&#x0002b;</sup>mobilization in platelets</article-title><source>J Biol Chem</source><year>1993</year><volume>268</volume><fpage>2277</fpage><lpage>2279</lpage><pub-id pub-id-type="pmid">8428900</pub-id></citation></ref><ref id="B71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uehata</surname><given-names>M</given-names></name><name><surname>Ishizaki</surname><given-names>T</given-names></name><name><surname>Satoh</surname><given-names>H</given-names></name><name><surname>Ono</surname><given-names>T</given-names></name><name><surname>Kawahara</surname><given-names>T</given-names></name><name><surname>Morishita</surname><given-names>T</given-names></name><name><surname>Tamakawa</surname><given-names>H</given-names></name><name><surname>Yamagami</surname><given-names>K</given-names></name><name><surname>Inui</surname><given-names>J</given-names></name><name><surname>Maekawa</surname><given-names>M</given-names></name><name><surname>Narumiya</surname><given-names>S</given-names></name></person-group><article-title>Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension</article-title><source>Nature</source><year>1997</year><volume>389</volume><fpage>990</fpage><lpage>994</lpage><pub-id pub-id-type="pmid">9353125</pub-id></citation></ref><ref id="B72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ushikubi</surname><given-names>F</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Narumiya</surname><given-names>S</given-names></name></person-group><article-title>Functional reconstitution  of platelet thromboxane A<sub>2</sub> receptors with G<sub>q</sub> and G<sub>i2</sub>in phospholipid vesicles</article-title><source>Mol Pharmacol</source><year>1994</year><volume>46</volume><fpage>808</fpage><lpage>816</lpage><pub-id pub-id-type="pmid">7969066</pub-id></citation></ref><ref id="B73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>S</given-names></name><name><surname>Reynolds</surname><given-names>AB</given-names></name><name><surname>Papkoff</surname><given-names>J</given-names></name></person-group><article-title>Platelet activation leads to increased c-src kinase activity and association of c-src with an 85-kDa tyrosine phosphoprotein</article-title><source>Oncogene</source><year>1992</year><volume>7</volume><fpage>2407</fpage><lpage>2415</lpage><pub-id pub-id-type="pmid">1281303</pub-id></citation></ref><ref id="B74"><citation citation-type="other">Wurzinger, L.J. 1990. Histophysiology of the Circulating Platelet. Springer-Verlag, Berlin, Germany. 96 pp.</citation></ref></ref-list></back></article>


